Stockwinners Market Radar for August 14, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
DNA | Hot Stocks20:07 EDT Cathie Wood's ARK Investment bought 850K shares of Ginkgo Bioworks today
|
SAWLF TS | Hot Stocks19:04 EDT Mattr to sell a substantial part of its pipeline segment to Tenaris for C$220M - Mattr (SAWLF) announced that it has entered into a definitive agreement to sell a substantial part of its pipe coating division to Tenaris S.A. (TS), including its wholly owned operations in Canada, the US, Mexico, Norway, the UAE and Indonesia, several mobile concrete coating plants, its joint-venture interest in Azerbaijan, its world-class research and development capabilities in Toronto and Norway, and a broad portfolio of intellectual property. The transaction will involve a mixture of legal entity and asset sales, and is subject to customary closing conditions, including regulatory approvals, which the company currently anticipates will be completed within approximately six months. The company will retain all earnings from the business until the transaction closes, and upon closing, the Company expects to receive gross sale proceeds of approximately $166M, or approximately C$220M at current exchange rates, on a cash-free, debt-free basis, subject to normal working capital adjustments. The perimeter of the transaction does not include entities of the PPG business in Malaysia, Italy, the United Kingdom and Brazil, which the company remains committed to exit at the appropriate time.
|
AAMC | Hot Stocks17:54 EDT Altisource Asset Management falls 59% as company considers EV investment - Shares of Altisource Asset Management are down 59% or $19.34 at $13.50 per share. In its Q2 earnings conference call, the company states: "As we review our lending business and as we continue our search for additional capital light asset management businesses that could be accretive to our business and shareholder value. We want to report an interesting opportunity. We recently received a proposal regarding a new technology developed by R&D venture led by AMC shareholder William Erbey. We invited Bill to join the call today to present this opportunity as he will explain this patented breakthrough technology is designed to substantially reduce energy loss and heat generation in electric vehicles, thereby increasing the range and efficiency given the enormous addressable EV market. These technology advances have significant upside potential. The opportunity is a pure intellectual property licensing play with low capital requirements. Structure and other details are still under discussion. But we have agreed in principle that the company's upfront cash commitment would be zero. The company's primary out-of-pocket expenses would be approximately 7 to 8 million in working capital over the next 18 to 24 months. These amounts would be expended as the technology is positioned for full commercialization. There would be a stock based earn out in increments of 10% of company stock earned when our share price exceeds $100. And as the share climbs above each $100 threshold thereafter, adjusted for appreciation attributed to lending."
|
GSM | Hot Stocks17:52 EDT Ferroglobe backs FY23 EBITDA view of $270M-$300M - The company states: "While end markets remain soft, our proactive energy strategy, combined with disciplined costs controls, is bolstering our performance in 2023. Hence, we are reiterating our guidance for the full year of adjusted EBITDA of $270 to $300 million."
|
NVTS | Hot Stocks17:50 EDT Navitas Semiconductor jumps 9% to $9.35 after Q2 results and guidance
|
SPRU | Hot Stocks17:49 EDT Spruce Power Holding announces disaster relief initiative - Spruce Power Holding announced a disaster relief initiative in the aftermath of the devastating fires that have swept through the Maui community. Spruce stands with its customers and will waive its billing for all customers within the impacted communities for the next 3 months. This relief is intended to provide immediate support to customers and their community, whether or not their system is known to be damaged or lost. Additionally, Spruce has committed a direct cash donation to any Spruce customer who lost a home power system in the fire. This is intended to accelerate our customers' recovery steps and help cover their additional energy costs while damaged or destroyed systems are inoperable.
|
AAMC | Hot Stocks17:48 EDT Altisource Asset Management falls 59% as company considers EV investment - Shares of Altisource Asset Management are down 59% or $19.34 at $13.50 per share. In its Q2 earnings conference call, the company states: "As we review our lending business and as we continue our search for additional capital light asset management businesses that could be accretive to our business and shareholder value. We want to report an interesting opportunity. We recently received a proposal regarding a new technology developed by R&D venture led by AMC shareholder William Urby. We invited Bill to join the call today to present this opportunity as he will explain this patented breakthrough technology is designed to substantially reduce energy loss and heat generation in electric vehicles, thereby increasing the range and efficiency given the enormous addressable EV market. These technology advances have significant upside potential. The opportunity is a pure intellectual property licensing play with low capital requirements. Structure and other details are still under discussion. But we have agreed in principle that the company's upfront cash commitment would be zero. The company's primary out-of-pocket expenses would be approximately 7 to 8 million in working capital over the next 18 to 24 months. These amounts would be expended as the technology is positioned for full commercialization. There would be a stock based earn out in increments of 10% of company stock earned when our share price exceeds $100. And as the share climbs above each $100 threshold thereafter, adjusted for appreciation attributed to lending."
|
HWM... | Hot Stocks17:47 EDT Elliott buys Seadrill, exits PayPal in Q2 - Paul Singer's Elliott Management disclosed in an SEC filing its holdings as of June 30, 2023. The fund's eight new buys during the second quarter included, by size of position, Seadrill (SDRL), Syneos Health (SYNH), Constellation Brands (STZ), NRG Energy (NRG), and Phillips 66 (PSX). Elliott exited two positions during the quarter, namely Clarivate (CLVT) and PayPal (PYPL). The fund increased its stake in six holdings, including by size of previous position Liberty Broadband Class C (LBRDK), iShares iBoxx High Yield Corporate Bond ETF (HYG), Endeavor Group (EDR), Pinterest (PINS), and E2open (ETWO). Elliott reduced its stake in four holdings, including by size of previous position Howmet Aerospace (HWM), iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), Valaris (VAL), and Bausch Health (BHC). The fund's top holdings as of June 30, in order of size were Triple Flag Precious Metals (TFPM), Marathon Petroleum (MPC), Howmet, Pinterest, and Peabody Energy (BTU).
|
AMZN... | Hot Stocks17:39 EDT Third Point buys Nvidia, exits Salesforce in Q2 - Third Point LLC disclosed in an SEC filing its holdings as of June 30, 2023. The fund's 12 new buys during the second quarter included, by size of position, Amazon (AMZN), TSMC (TSM), Nvidia (NVDA), Intercontinental Exchange (ICE), and Activision Blizzard (ATVI). Third Point exited 12 positions during the quarter, including by size of previous position Colgate-Palmolive (CP), Salesforce (CRM), UnitedHealth (UNH), National Instruments (NATI), and Teck Resources (TECK). The fund increased its stake in 12 holdings, including by size of previous position Microsoft (MSFT), Jacobs Solutions (J), Denbury (DEN), Alibaba (BABA), and DuPont (DD). Third Point reduced its stake in six holdings, including by size of previous position Alphabet Class A (GOOGL), Danaher (DHR), HCA Healthcare (HCA), PG&E (PCG), and Global Blue Group (GB). The fund's top holdings as of June 30, in order of size, were PG&E, Danaher, Amazon, Bath & Body Works (BBWI), and Microsoft.
|
DFS | Hot Stocks17:24 EDT Discover confirms CEO Roger Hochschild steps down, John Owen interim CEO - Discover Financial Services announced that the Discover Board of Directors and Roger Hochschild have agreed that Hochschild will step down as CEO and President and as a member of the Board. Hochschild will serve in an advisory role at the company through the end of the year to ensure a smooth transition. John Owen, a member of the Board, has been appointed Interim CEO and President. These changes are effective immediately. The Board has engaged a leading global executive search firm to commence a process to identify a permanent CEO and President.
|
AGIL | Hot Stocks17:11 EDT AgileThought reports Q2 adjusted EPS (13c), consensus (9c) - Reports Q2 revenue $38.33M, consensus $41.26M. "I am proud of our second quarter achievements. While the market volatility and our ongoing efforts to exit non-core revenues has impacted our results this quarter, we feel confident about the future as we continue to build our pipeline and deliver top of the line services to our clients. We look forward enhancing relationships with new and current clients by staying at the forefront of transformational technologies and innovations," commented AgileThought CEO Manuel Senderos.
|
DFS RF | Hot Stocks17:11 EDT Discover CEO Roger Hochschild resigns, John Owen named interim CEO - On August 13, the Board of Directors of Discover Financial Services (DFS) accepted the resignation of Roger Hochschild from his positions as CEO and President of the company, a member of the Board and a director and officer of Discover Bank, each effective August 14. To assist with the transition, Hochschild will continue to be employed by the company as an advisor to the Chair of the Board from the Effective Date through December 31, 2023, pursuant to the terms of a transition employment letter. The Board has established a special search committee to conduct a search for a permanent successor to Hochschild. On August 13, the Board appointed John Owen as Interim CEO and Interim President of the company and as Interim President of the Bank, effective August 14. Owen will continue to serve as a director of the company, but is resigning as a member of the Risk Oversight Committee of the Board during his term as Interim CEO and Interim President. John Owen, a financial services veteran with more than 38 years of experience in banking and information technology that spans multiple industries including banking, insurance, airlines, and the defense industry, was elected to the Board and appointed to the Board's Risk Oversight Committee on June 6, 2022. Prior to joining the company, Owen retired from Regions Financial (RF).
|
EQIX | Hot Stocks17:09 EDT Equinix CEO sells $5.73M in common stock - In a regulatory filing, Equinix disclosed that its CEO Charles Meyers sold 7.4K shares of common stock on August 11th in a total transaction size of $5.73M.
|
LL | Hot Stocks17:01 EDT LL Flooring to explore strategic alternatives, including potential sale - LL Flooring announced that its Board of Directors has initiated an exploration of strategic alternatives in response to receipt of multiple inbound expressions of interest regarding a potential transaction with the company. As part of this process, the Board will consider a wide range of options for the company including, among other things, a potential sale, merger or other strategic transaction. Nancy Taylor, Independent Chairperson of the Board of Directors, said, "The LL Flooring Board of Directors has confidence in the company's strategy and believes that the strategic work the management team has been doing to strengthen the business will provide long-term benefits. While this work is well underway, in light of external interest in the company, the Board and management are taking the opportunity to explore a range of potential strategic alternatives to maximize shareholder value. We look forward to working diligently with our external advisors to identify the best path for the future of LL Flooring and all of our shareholders." As previously disclosed on June 26, 2023, the company's Board of Directors unanimously rejected an unsolicited, non-binding proposal to acquire all of LL Flooring's outstanding shares for $5.76 per share in cash as it significantly undervalued the worth of LL Flooring, its business and prospects. As the Board noted at that time in rejecting the proposal, it remains open to considering a transaction that appropriately reflects the company's value and prospects. There can be no assurance that the company's strategic alternatives process will result in LL Flooring pursuing any particular transaction or other strategic outcome. The company has not set a timetable for completion of this process, and it does not intend to disclose further developments unless and until it determines that further disclosure is appropriate or necessary.
|
MDGL... | Hot Stocks16:52 EDT Paulson buys Madrigal, exits Bally's in Q2 - John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of June 30, 2023. The fund's five new buys during the second quarter included, by size of position, Madrigal Pharma (MDGL), SSR Mining (SSRM), and Newmont (NEM). Pauslon exited three positions during the quarter, including Bally's (BALY). The fund decreased its stake in one holding, namely Horizon Therapeutics (HZNP). Paulson's top holdings as of June 30, in order of size, were Bausch Health (BHC), Brightsphere Investment (BSIG), Perpetua Resources (PPTA), Novagold (NG), and Madrigal.
|
COLM | Hot Stocks16:48 EDT Columbia Sportswear names Woody Blackford Chief Product Officer, Columbia brand - Columbia Sportswear has hired Woody Blackford as Senior Vice President, Chief Product Officer for the Columbia Brand. Mr. Blackford is returning to Columbia, where he previously worked for 14 years, culminating in the position of Vice President, Global Design and Innovation.
|
LNG... | Hot Stocks16:47 EDT Icahn exits Cheniere Energy, boosts Southwest Gas in Q2 - Carl Icahn's Icahn Capital disclosed in an SEC filing its holdings as of June 30, 2023. The fund exited two positions during the quarter, including by size of previous position Cheniere Energy (LNG) and Herc Holdings (HRI). Icahn increased its stake in two holdings, namely Southwest Gas (SWX) and Icahn Enterprises (IEP). The fund decreased its stake in one holding, namely FirstEnergy (FE). Icahn Capital's top holdings as of June 30, in order of size, were Icahn Enterprises, CVR Energy (CVI), Southwest Gas, FirstEnergy, and Xerox (XRX).
|
LYV... | Hot Stocks16:46 EDT Lone Pine adds Live Nation, Nvidia stakes, exits AMD position - Stephen Mandel's Lone Pine Capital disclosed in an SEC filing its holdings as of June 30, 2023. Lone Pine's two new buys during the second quarter included, by size of position, Live Nation (LYV) and Nvidia (NVDA). Lone Pine exited two positions during the quarter, including by size of previous position, AMD (AMD) and Valaris (VAL). Lone Pine increased its stake in six holdings, including by size of previous position, PTC Inc. (PTC), Floor & Decor (FND), HDFC Bank (HDB), Mastercard (MA), and LPL Financial (LPLA). Lone Pine reduced its stake in nine holdings, including by size of previous position, Workday (WDAY), Dick's Sporting Goods (DKS), Taiwan Semiconductor (TSM), Bath & Body Works (BBWI), and Salesforce (CRM). Lone Pine's top holdings as of June 30, in order of size, were Microsoft (MSFT), Taiwan Semiconductor, Amazon (AMZN), Bath & Body Works, and RH (RH).
|
DSGN | Hot Stocks16:39 EDT Design: Variability of results limited utility of FXN protein measurement - The company noted, "FXN protein measurements in skeletal muscle had substantial overlap between FA patients and carriers and showed high intra-individual variability. More than half of FA patients had 25% or more variation in FXN protein levels between visits, with intra-individual coefficient of variation of 69%. The variability of results observed with this current method substantially limited the utility of FXN protein measurements to assess DT-216 pharmacology."
|
DIS... | Hot Stocks16:37 EDT Trian takes new stake in Disney, reduces stake in Wendy's - Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of June 30-, 2023. Trian 's one new buy during the second quarter was Disney (DIS). Trian reduced its stake in two holdings, including by size of previous position, Wendy's (WEN) and Ferguson (FERG). Trian's top holdings as of June 30, in order of size, were Janus Henderson (JHG), Ferguson, Disney, Invesco Ltd. (IVZ), and Wendy's.
|
ATVI... | Hot Stocks16:36 EDT Greenlight buys Seadrill, cuts Teck in Q2 - David Einhorn's Greenlight Capital disclosed in an SEC filing its holdings as of June 30, 2023. The fund's six new buys during the second quarter included, by size of position, Activision Blizzard (ATVI), First Horizon (FHN), Seadrill (SDRL), Herc Holdings (HRI), and Advance Auto Parts (AAP). Greenlight exited four positions during the quarter, including by size of previous position Global Payments (GPN), Civitas Resources (CIVI), and Concentrix (CNXC). The fund increased its stake in seven holdings, including by size of previous position Consol Energy (CEIX), Black Knight (BKI), Net Power (NPWR), Graphic Packaging Holding (GPK), and Southwestern Energy (SWN). Greenlight reduced its stake in 11 holdings, including by size of previous position Kyndryl (KD), Teck Resources (TECK), Tenet (THC), iShares Silver Trust (SLV), and Weatherford (WFRD). The fund's top holdings as of June 30, in order of size, were Green Brick (GRBK), Consol Energy, Brighthouse Financial (BHF), Black Knight, and Tenet.
|
TCRT | Hot Stocks16:35 EDT ZIOPHARM Oncology trading resumes
|
ROG | Hot Stocks16:30 EDT Rogers Corporation names Griffin Gappert CTO - Rogers Corporation announced that Griffin Gappert, Ph.D. has joined the company as Vice President and Chief Technology Officer. He will lead Rogers' global Research and Development organization and partner with business unit leaders to drive innovation and commercialization of next-generation material solutions. Griffin joins Rogers from Henkel where he was the Global Head of Innovation for Henkel's Adhesives Automotive OEM business, based in Germany. He brings more than 20 years of experience in the specialty materials and chemicals industries to Rogers. Prior to joining Henkel, Griffin held leadership roles at Ashland Inc., Dow Chemical Company and The Rohm and Haas Company. Griffin holds a PhD in Chemical Engineering from the University of Massachusetts at Amherst and an MBA from the Wharton School of the University of Pennsylvania.
|
DBX | Hot Stocks16:25 EDT Dropbox CFO sells $2.08M in common stock - In a regulatory filing, Dropbox disclosed that its CFO Timothy Regan sold 75K shares of common stock on August 10th in a total transaction size of $2.08M.
|
AMT | Hot Stocks16:20 EDT American Tower CFO Smith sells 2,727 common shares - In a regulatory filing, American Tower CFO Rodney Smith disclosed the sale of 2,727 common shares of the company on August 10 at a price of $187.17 per share.
|
AREN | Hot Stocks16:17 EDT Arena Group signs binding LOI to combine with Bridge Media Networks - The Arena Group announced that it has signed a binding letter of intent with Simplify Inventions and its founder, Manoj Bhargava, founder of 5-hour ENERGY, to acquire certain assets of its subsidiary Bridge Media Networks, a dynamic and innovative, privately held media group with two national television networks distributed across more than 100 owned and affiliated Over-The-Air stations, 35 OTT, CTV agreements, and multiple MVPD and cable agreements, creating a well-capitalized, growing media leader with digital, commerce, print and video capabilities all supported by a unified technology platform. "This strategic combination dramatically accelerates our planned expansion across the video ecosystem. Our immediate opportunity to create, distribute and monetize premium video content across all linear, digital and connected ecosystems provides a lucrative opportunity for The Arena Group. The production capabilities and opportunities with advertisers will further diversify our offerings," commented Ross Levinsohn, Chairman and Chief Executive Officer of The Arena Group. "By combining with two established networks with significant linear and digital distribution, The Arena Group will have a significant presence in OTT, CTV, and Free Ad Support Television ("FAST") channels, some of the fastest-growing segments of the video market. The production resources of Bridge Media Networks will provide a dramatic boost to our video capabilities which we believe will unlock significant revenue opportunities for the combined company. The result will be a more diverse and distributed organization with additional ways to reach consumers and support advertising clients across video platforms." The transaction is expected to close in the fourth quarter of 2023, subject to negotiation of definitive agreements, the completion of due diligence, the approval of The Arena Group's shareholders, the receipt of any required regulatory approvals, and certain other closing conditions. The Company anticipates that integration of the respective businesses will be completed in early 2024.
|
LEN | Hot Stocks16:17 EDT Lennar jumps 2% to $126.30 after Berkshire discloses new stake
|
DHI | Hot Stocks16:16 EDT D.R. Horton jumps 3% to $126.98 after Berkshire discloses 5.97M share stake
|
FXLV | Hot Stocks16:15 EDT F45 Training to delist from NYSE - F45 Training "announced its intention to voluntarily delist from the New York Stock Exchange and to deregister its common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended, as well as suspend its reporting obligations under Section 15(d) of the Exchange Act. As previously disclosed, the Company received a notice from the NYSE that it is not currently in compliance with the continued listing standards of the NYSE because the Company is behind in its public filings and because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period. Since receipt of such notice, the Company's common stock has generally continued to trade below $1.00 per share. In response, the Company has evaluated whether to remain listed or to go dark and has determined that going dark is the best path for the Company due to the expected substantial cost savings and the Company's current inability to realize the traditional benefits of public company status. The Company's continued low trading value, and the resulting low trading price, affects the Company's ability to raise capital from the public markets, effectively use its securities as transaction consideration or attract interest from institutional investors or market analysts. Despite the lack of these benefits, the Company incurs all of the significant annual expenses and indirect costs associated with being a public company. As a result of going dark, the Company will no longer be obligated to pay these significant expenses and will experience substantial cost savings."
|
DHI... | Hot Stocks16:12 EDT Berkshire Hathaway takes new stake in D.R. Horton, exits McKesson position - Warren Buffett's Berkshire Hathaway disclosed in an SEC filing its holdings as of June 30, 2023. Berkshire Hathaway's three new buys during the second quarter included, by size of position, D.R. Horton (DHI), NVR (NVR), and Lennar (LEN). Berkshire Hathaway exited three positions during the quarter, including by size of previous position, McKesson (MCK), Marsh & McLennan (MMC), and Vitesse Energy (VTS). Berkshire Hathaway increased its stake in two holdings, including by size of previous position, Capital One (COF) and Occidental Petroleum (OXY). Berkshire Hathaway reduced its stake in five holdings, including by size of previous position, Activision Blizzard (ATVI), Chevron (CVX), General Motors (GM), Globe Life (GL), and Celanese (CE). Berkshire Hathaway's top holdings as of June 30, in order of size, were Apple (AAPL), Bank of America (BAC), American Express (AXP), Coca-Cola (KO), and Chevron.
|
HRTX | Hot Stocks16:09 EDT Heron reaffirms FY23 oncology care franchise revenue view $99M-$103M
|
ZVIA | Hot Stocks16:08 EDT Zevia announces CFO transition - Zevia PBC "announced that Florence Neubauer, Zevia's current Senior Vice President, Financial Planning & Analysis, has been appointed Interim Chief Financial Officer, replacing Denise D. Beckles, who will be leaving the Company effective September 4, 2023, to pursue another opportunity. The Company has launched a formal search process to identify a permanent replacement."
|
ID | Hot Stocks16:07 EDT Parts iD announces acceptance of compliance plan by NYSE - PARTS iD "announced that the NYSE American has accepted the Company's business plan to regain compliance with the Exchange's continued listing standards regarding stockholders' equity, as set forth in Sections 1003(a)(i), (ii) and (iii) of the NYSE American Company Guide. As previously reported, on May 23, 2023, the Company received notification from the NYSE American that it was not in compliance with the continued listing standards set forth in the NYSE American Company Guide. Specifically, the Letter indicated that the Company was not in compliance with Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide, requiring a listed company to have stockholders' equity of (i) at least $2.0 million if it has reported losses from continuing operations or net losses in two of its three most recent fiscal years and (ii) at least $4.0 million if it has reported losses from continuing operations or net losses in three of its four most recent fiscal years. The Company submitted a plan of compliance to the Exchange on June 22, 2023 addressing how the Company intends to regain compliance with these requirements by November 23, 2024."
|
NVTA | Hot Stocks16:05 EDT Invitae appoints Robert Dickey as interim CFO - Invitae announced that Robert Dickey has been named its interim CFO, effective immediately. Christine Gorjanc, who had assumed the interim CFO role in June 2023, will transition back to her prior role as the Company's Chair of the Audit Committee of the Board of Directors and member of the Compensation Committee of the Board of Directors, effective immediately. Gorjanc will work closely with Mr. Dickey and the executive leadership team to ensure a smooth transition. She will also continue to assist the Company with the search for its permanent CFO. Dickey is a finance executive with over 25 years experience as a CFO as well as other C-level and board positions at both private and publicly traded life sciences and medical device companies. Dickey is experienced in all stages of the corporate lifecycle, including start-up and fundraising, the IPO process, high growth and turnarounds as well as interactions with directors, shareholders and the investment community.
|
ACLX | Hot Stocks16:04 EDT Arcellx announces FDA lifted clinical hold for iMMagine-1 Phase 2 program - Arcellx announced clinical hold and clinical hold lifted by FDA for the company's iMMagine-1 Phase 2 Clinical Program. On June 19, 2023, Arcellx announced that its iMMagine-1 study had been placed on partial clinical hold by FDA following a recent patient death, which involved a patient who was treated with CART-ddBCMA despite becoming ineligible for treatment under the trial protocol prior to CART-ddBCMA infusion. Subsequently, the patient was managed in a manner that conflicted with the trial protocol. On August 14, 2023, Arcellx announced that FDA had lifted the partial clinical hold after aligning with FDA on modifications to the iMMagine-1 trial protocol related to the prevention and management of the risk of adverse events within the trial. As a key effort to enhance protocol adherence, Arcellx retrained clinical sites. Additionally, FDA allowed an expansion of treatment options for therapies that patients in the iMMagine-1 trial are permitted to receive between apheresis and CAR-T infusion to better align its protocol with current clinical practice. The company anticipates presenting preliminary data from the iMMagine-1 study in the second half of 2024.
|
PHR | Hot Stocks16:03 EDT Phreesia acquires Access eForms, terms not stated - Phreesia announced it has acquired Access eForms, an electronic forms management and automation provider that helps hospitals across the country streamline workflows, improve compliance and deliver a better patient experience. Access eForms was founded over 20 years ago, collects more than 1.6 billion e-signatures each year, and currently works with many of Phreesia's existing clients.
|
TCRT | Hot Stocks16:01 EDT ZIOPHARM Oncology trading halted, news pending
|
EFSH | Hot Stocks15:40 EDT 1847 Holdings says may have been target of market manipulation - 1847 Holdings provided a report on its ongoing investigation into potentially improper and/or illegal trading activities, including naked short selling, of the company's common stock. On November 3, 2022, the company engaged Shareholder Intelligence Services to utilize their patented, proprietary service offerings to obtain share trading analytic metrics designed to help coordinate, monitor and enhance corporate governance, shareholder communication, regulatory compliance and surveillance of trading in the company's shares in an effort to allow company to better monitor trading activity, including potential violations of SEC Regulation SHO, which governs stock and option share locate, close out and fail to deliver requirements. Based on an initial analysis of the company's historic stock trading activity, the company believes that it may have been the target of market manipulation and potentially illegal trading activities, including naked short selling of its stock. As such, the company is exploring all of its potential options and remedies. Ellery W. Roberts, CEO of 1847 Holdings, commented, "Due to ShareIntel's investigation, we have become aware of trading imbalances. We will delve deeper into the discrepancies identified in the analysis and contact necessary parties such as brokers, Broadridge, and the SEC to gather more information and ensure adherence to regulatory standards. We remain diligent and committed to taking all necessary actions to protect the interests of our shareholders, and will continue to work with ShareIntel and other partners to combat illegal short selling."
|
DLO | Hot Stocks15:34 EDT DLocal jumps 9% to $13.76 after Bloomberg says exploring sale
|
UBSFY | Hot Stocks15:27 EDT Ubisoft moves up 'Assassin's Creed Mirage' release date to October 5 - Ubisoft said that "Assassin's Creed Mirage" has gone gold and will be releasing October 5, a week earlier than originally planned. "On behalf of the entire team, we can't wait for you to explore 9th Century Baghdad with Basim," the company said. Reference Link
|
LDOS... | Hot Stocks15:10 EDT Jana buys Leidos during Q2, exits BlackSky Technology - Barry Rosenstein's Jana Partners disclosed in an SEC filing its holdings as of June 30, 2023. The fund made one new purchase during Q2, buying 324,930 shares of Leidos (LDOS). Jana firm exited one position during Q2, selling 2.88M shares of BlackSky Technology (BSKY). The fund increased its stake in five holdings: Mercury Systems (MRCY), Freshpet (FRPT), FIS (FIS), TreeHouse Foods (THS) and Enhabit (EHAB). Jana decreased its stake in two holdings: Labcorp (LH) and SPDR S&P 500 ETF Trust (SPY). Jana's top holdings as of June 30, in order of size, were Freshpet, TreeHouse, New Relic (NEWR), FIS and Mercury Systems.
|
X CLF | Hot Stocks15:03 EDT U.S. Steel spikes 41% to $31.95 after Esmark tops Cleveland-Cliffs bid
|
X CLF | Hot Stocks15:02 EDT Esmark joins bidding for U.S. Steel with $35 per share bid - Esmark announced a voluntary public cash and exchange offer for all issued and outstanding shares in U.S. Steel (X) for $35 per share. The initial offer period runs from August 14, to November 30, and may be extended. Completion of the offer is expected in Q4, subject to regulatory and antitrust clearances. "With more than 40 years of steel industry experience, and as a former executive and statutory representative of U.S. Steel, I have significant intimacy with the steel business in the U.S. and around the globe," said James Bouchard, Chairman & CEO of Esmark. Bouchard continued, "This is an exciting time as the entire American Steel industry is restructuring, and with Esmark's long-standing history of excellence, we are anxious to continue to grow and we're well positioned to come in and operate." Prior to founding Esmark, Bouchard was Vice President-Commercial for U.S. Steel in Europe. Cleveland-Cliffs (CLF) yesterday announced a previously private offer that it had presented to the board of the U.S. Steel on July 28. That offer proposed acquiring 100% of the outstanding stock of U.S. Steel for a per share value of $17.50 in cash and 1.023 shares of Cliffs stock. On July 28, the implied a total consideration value of $35.00 per share of U.S. Steel stock.
|
X CLF | Hot Stocks14:58 EDT Esmark announces offer to acquire U.S. Steel for $35 per share in cash
|
SNAP... | Hot Stocks14:57 EDT SRS bought 52.7M shares of Snap during Q2 - Karthik Sarma's SRS Investment Management disclosed six new purchases during the second quarter, the top new buy being 52.7M shares of Snap. SRS also acquired 225,372 shares of Nvidia (NVDA) and 768,027 shares of TSMC (TSM). Snap in afternoon trading is down 1% to $9.91.
|
LLY... | Hot Stocks14:52 EDT Tiger Global buys Eli Lilly, exits Block in Q2 - Chase Coleman's Tiger Global disclosed in an SEC filing its holdings as of June 30, 2023. The fund's two new buys during the second quarter included, by size of position, Eli Lilly (LLY) and Novo Nordisk (NVO). Tiger exited 17 potisions during the quarter, including by size of position Mastercard (MA), Apple (AAPL), Block (SQ), XP Inc. (XP), and Applied Materials (AMAT). The fund increased its stake in ten holdings, including by size of previous position Meta Platforms (META), Apollo Global (APO), Take-Two (TTWO), Intuit (INTU), and Nvidia (NVDA). Tiger reduced its stake in 19 holdings, including by size of previous position Amazon (AMZN), Alphabet Class A (GOOGL), JD.com (JD), Snowflake (SNOW), and Datadog (DDOG). The fund's top holdings as of June 30, in order of size, were Meta, Microsoft (MSFT), Apollo, JD.com, and Take-Two.
|
PFE | Hot Stocks14:09 EDT Pfizer's Elrexfio receives FDA accelerated approval - Pfizer announced the U.S. Food and Drug Administration has granted accelerated approval to ELREXFIO for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. Approval was based on the results of the single-arm Phase 2 MagnetisMM-3 trial, and continued approval for this indication is contingent upon verification of clinical benefit in a confirmatory trial(s). ELREXFIO is a subcutaneously delivered B-cell maturation antigen (BCMA)-CD3-directed bispecific antibody immunotherapy that binds to BCMA on myeloma cells and CD3 on T-cells, bringing them together and activating the T-cells to kill myeloma cells. "ELREXFIO reflects our ongoing commitment to developing scientific breakthroughs that meaningfully improve outcomes for people with cancer. Discovered at Pfizer, we advanced this therapy from a first-in-patient trial to approval in less than five years, because we know that time is life for people living with multiple myeloma," said Angela Hwang, Chief Commercial Officer and President of Global Biopharmaceuticals Business, Pfizer. "With significant responses in a patient population with highly refractory disease, we believe ELREXFIO is poised to potentially become the new standard of care for multiple myeloma, as we plan to build upon this indication with continued development across the expansive MagnetisMM program."
|
CBAY | Hot Stocks13:30 EDT CymaBay VP Daniel Menold sells $259K in company shares - CymaBay VP Daniel Menold disclosed in a regulatory filing the sale of 20,945 shares of company stock at $12.35 per share on August 9, for a total transaction amount of $258,744.
|
GE | Hot Stocks13:22 EDT GE Vernova acquires Greenbird Integration Technology; terms not disclosed - GE Vernova's Digital business announced it has acquired Greenbird Integration Technology AS, a data integration platform company focused on utilities. This acquisition highlights GE Vernova's commitment to investing in technologies and talent that help accelerate the sustainable energy grid, the company said in a statement, adding that the platform will accelerate GridOS. The financial terms of the acquisition are not being disclosed. Scott Reese, CEO of GE Vernova's Digital business, said "The Greenbird acquisition brings the proven ability to connect multiple data sources and accelerates our vision for GridOS that is making energy security a reality for many of the world's leading utilities. Data and AI are key to helping utilities run a reliable and resilient grid and this acquisition is a massive accelerant to making that vision a reality for utilities of all sizes."
|
TRIP | Hot Stocks13:17 EDT TripAdvisor downgraded to B+ by S&P with stable outlook - S&P Global Ratings downgraded its issuer credit rating and issue-level ratings on Tripadvisor to 'B+' from 'BB-'. S&P said: "The downgrade to 'B+' reflects our view that Tripadvisor's leverage remains high for the current rating due to an unfavorable business mix and near-term softness in the company's metasearch business." S&P expects profitability for Tripadvisor will remain pressured in 2023 as its strong revenue growth is offset by a new operating plan to drive engagement and continued investments in its less profitable businesses like Viator and TheFork. The stable outlook reflects the view that Tripadvisor's leverage will likely improve to the low-3x area in the next 12 months as the company's recent new monetization strategy and increased competition in the hotel metasearch business partially offset healthy online travel trends.
|
UBS | Hot Stocks13:02 EDT UBS to pay $1.435B to settle RMBS matter with U.S. DOJ - UBS has reached an agreement with the United States Department of Justice to settle a legacy matter from 2006-2007, related to the issuance, underwriting and sale of residential mortgage-backed securities. Under the terms of the settlement, UBS will pay $1.435B to resolve all civil claims by the DOJ in connection with UBS's legacy RMBS business in the US. The settlement has been fully provisioned in prior periods.
|
LVO PODC | Hot Stocks12:58 EDT LiveOne's PodcastOne approved to trade on Nasdaq - LiveOne announced its Courtside Group, dba PodcastOne, subsidiary has been approved for listing on Nasdaq. "PODC" has been reserved as the trading symbol for PodcastOne's common stock.
|
FCN | Hot Stocks12:50 EDT FTI Consulting director Bartlett sells 3,340 common shares - In a regulatory filing, FTI Consulting director Mark Bartlett disclosed the sale of 3,340 common shares of the company on August 11 at a price of $188.97 per share.
|
VOCL | Hot Stocks12:36 EDT Creatd has reduced payroll costs by almost 40% to $721,000 in Q2 - Despite a slight drop in quarterly revenues, Creatd said it has strategically refocused on profitable core businesses, causing the revenue decline. This, coupled with staff reductions and austerity steps, has reduced payroll costs by almost 40%, from $1.2M in 2022 to $721,000 in Q2 2023. This is projected to decrease further next quarter, Creatd said. Annual fees for legal, accounting, and consulting have also dropped by nearly 60%, from $850,000 to $300,000. Service expenses have been reduced company-wide, the company added.
|
VOCL | Hot Stocks12:35 EDT Creatd structures Vocal as private subsidiary - Creatd announced that it has successfully structured Vocal, Inc., as a private subsidiary to independently house and raise capital for the Vocal technology platform. This decision stems from the management team's belief in Vocal's intrinsic value in the private market, estimated to be between $60M-$100M. Recent private valuations of the company's competitors have been estimated at between $600M-$1B. The company intends to eventually create enough shareholder support to IPO Vocal, Inc. separate and apart from the holding company. Vocal, Inc. is gearing up to launch a Regulation Crowdfunding raise, in which Creatd will maintain majority ownership of the subsidiary. The offering will be up to $5M in a high-yielding participating preferred security specific to the private company Vocal, Inc. and not directly tied to Creatd's common stock. Chairman and CEO Jeremy Frommer said, "In today's markets, individual pieces of a business are greater than the sum of the whole. It is quite obvious to me that the holding company, Creatd, trading on the OTCQB for the last 12 months and our primary form of financing for the better part of the last decade, cannot be relied on in the current market for financing without too much dilution. As of today, I am actively engaged in constructive discussions with current bond holders and creditors regarding our strategic plan, and updates will be shared with the investor community as they materialize."
|
CRKN | Hot Stocks12:32 EDT Crown Electrokinetics announces 1-for-60 reverse stock split - Crown Electrokinetics announces that it expects to implement a 1-for-60 reverse stock split on its common stock effective 11:59 p.m. Eastern Time on Monday, August 14, 2023, with trading to begin on a split-adjusted basis at the market open on August 15, 2023. Trading in the common stock will continue on the Nasdaq Capital Market under the symbol "CRKN". The new CUSIP number for the common stock following the reverse stock split is 228339305. The reverse stock split at a ratio of 1-for-60 shares was approved by the Company's Board of Directors through unanimous written consent on August 11, 2023 and the Company's stockholders at the Annual Meeting which was held on August 11, 2023. Upon the effectiveness of the reverse stock split, every 60 shares of the Company's issued and outstanding common stock will automatically be converted into one share of issued and outstanding common stock. No fractional shares will be issued as a result of the reverse stock split. Instead, any fractional shares that would have resulted from the split will be rounded up to the next whole number. The reverse stock split affects all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's outstanding common stock, except for adjustments that may result from the treatment of fractional shares.
|
VZ | Hot Stocks12:30 EDT Verizon says it now has access to more 5G C-band spectrum - Verizon announced that it now has access to the total amount of 5G C-band spectrum awarded at auction in March 2021 - four months ahead of schedule. This allows Verizon to more quickly expand and enhance its 5G Ultra Wideband network nationwide, more than doubling and, in some markets, tripling the 5G bandwidth available to serve customers. This will provide much greater capacity to accommodate more customers and more robust services, as well as enable higher data speeds. This additional spectrum will also allow Verizon to offer 5G Home broadband and Business Internet services to more customers. "Early access to the remainder of the C-band spectrum puts us another four months ahead of schedule from our original projections. This additional spectrum will make 5G Ultra Wideband available to even more Americans, and will open up more availability of our home and business broadband solutions," said Joe Russo, EVP & President of Global Networks and Technology for Verizon. "The more spectrum we deploy on our network, the more capacity we add for our customer's to connect."
|
BLKB | Hot Stocks12:05 EDT Blackbaud names Todd Lant chief customer officer - Blackbaud appointed Todd Lant chief customer officer. Lant has been with Blackbaud for 20 years, most recently serving as chief information officer. "We're excited for the next chapter of our customer success program under Todd's leadership," said Kevin Gregoire, executive vice president and COO. "Todd has demonstrated outstanding business acumen and customer focus throughout his career at Blackbaud. He championed digital transformation across our business and has been deeply engaged with our customers throughout his tenure, offering advice and insights in his role as CIO, all while building strong teams and fostering a customer-centric culture internally."
|
LICY | Hot Stocks12:00 EDT Li-Cycle falls -10.6% - Li-Cycle is down -10.6%, or -58c to $4.91.
|
AMC | Hot Stocks12:00 EDT AMC Entertainment falls -32.9% - AMC Entertainment is down -32.9%, or -$1.73 to $3.53.
|
HE | Hot Stocks12:00 EDT Hawaiian Electric falls -33.8% - Hawaiian Electric is down -33.8%, or -$10.96 to $21.44.
|
IRRX | Hot Stocks12:00 EDT Integrated Rail and Resources Acquisition rises 10.0% - Integrated Rail and Resources Acquisition is up 10.0%, or $1.07 to $11.81.
|
ACHR | Hot Stocks12:00 EDT Archer Aviation rises 11.4% - Archer Aviation is up 11.4%, or 66c to $6.43.
|
X | Hot Stocks12:00 EDT U.S. Steel rises 29.4% - U.S. Steel is up 29.4%, or $6.68 to $29.40.
|
ZURVY | Hot Stocks11:01 EDT Zurich Holding Company of America acquires SpearTip; terms not disclosed - Zurich Holding Company of America, a subsidiary of Zurich Insurance Group, has acquired SpearTip, a cyber counterintelligence firm that helps protect clients against cyber threats through proactive and response services. This acquisition expands the cyber risk mitigation services available from Zurich Resilience Solutions, a global division of Zurich's Commercial Insurance Business, to support customers' growing needs for comprehensive cyber risk management support amidst a challenging risk landscape, the company said in a statement. Terms of the deal were not disclosed.
|
F AAPL | Hot Stocks10:59 EDT Ford appoints Peter Stern to lead Ford Integrated Services - Ford (F) named Apple (AAPL) veteran Peter Stern to lead the newly formed Ford Integrated Services, which will create and market valuable software-enabled customer experiences across Ford Blue, Model e and Ford Pro. Stern served as vice president of Services at Apple for more than six years through January 2023 and was a driving force behind the launch of Apple's portfolio of services. Stern who starts at Ford today and reports to President and CEO Jim Farley, will build a world-class team to: Build out the business tied to Ford's BlueCruise hands-free highway driving system and productivity and safety/security services, including those from the Ford Pro Intelligence business; Imagine and deliver exciting new high-value services, and Lead services marketing, certain out-of-vehicle customer experiences and Ford Next.
|
AMZN | Hot Stocks10:51 EDT Amazon uses generative AI to improve product reviews - The company said, "We want to make it even easier for customers to understand the common themes across reviews, and with the recent advancements in generative AI, we believe we have the technical means to address this long-standing customer need. Want to quickly determine what other customers are saying about a product before reading through the reviews? The new AI-powered feature provides a short paragraph right on the product detail page that highlights the product features and customer sentiment frequently mentioned across written reviews to help customers determine at a glance whether a product is right for them. Now available to a subset of mobile shoppers in the U.S. across a broad selection of products, the AI-generated review highlights also feature key product insights and allow customers to more easily surface reviews that mention certain product attributes. For example, a customer looking to understand whether a product is easy to use can easily surface reviews mentioning "ease of use" by tapping on that product attribute under the review highlights." Reference Link
|
AQN... | Hot Stocks10:35 EDT Starboard takes stake in Algonquin Power, exits position in Enovis - Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of June 30, 2023. Starboard's three new buys during the second quarter included, by size of position, Algonquin Power (AQN) and Abcam (ABCM). Starboard exited 61 positions during the quarter, including by size of previous position, Enovis (ENOV), On Semiconductor (ON), HCM Acquisition (HCMA), Papaya Growth Opportunity (PPYA), and Banyan Acquisition Corp. (BYN). Starboard increased its stake in two holdings, Wix.com (WIX) and Humana (HUM). Starboard reduced its stake in ten holdings, including by size of previous position, Willis Towers (WTW), Aecom (ACM), Mercury Systems (MRCY), Salesforce (CRM), and CommVault Systems (CVLT). Starboard's top holdings as of June 30, in order of size, were GoDaddy (GDDY), Splunk (SPLK), Salesforce, Humana, and Vertiv Holdings (VRT).
|
MEDS | Hot Stocks10:26 EDT Trxade Health files for extension for Form 10-Q filing - TRxADE HEALTH has filed for an extension to file its Quarterly Report on Form 10-Q for Q2 pursuant to a Form 12b-25 filed with the SEC. The Company is not able to timely file its 10-Q by August 14, 2023, the original due date for such filing, without unreasonable effort or expense, because additional time is required to finalize its financial statements and related disclosures required to be included in the 10-Q in connection with the recent merger transaction it completed in July. TRxADE will release financial results for the second quarter 2023, after market close on August 18, 2023
|
SAL NBTB | Hot Stocks10:25 EDT Salisbury Bancorp completes merger with NBT Bancorp - Salisbury Bancorp completed its merger with and into NBT Bancorp on August 11, 2023.
|
RNR... | Hot Stocks10:21 EDT Soros boosts stake in Amazon, exits position in First Horizon - George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of June 30, 2023. Soros' 23 new buys during the second quarter included, by size of position, RenaissanceRe Holdings (RNR), CRH PLC (CRH), General Motors (GM), Alibaba (BABA), and Pioneer Natural Resources (PXD). Soros exited 37 positions during the quarter, including by size of previous position, First Horizon (FHN), Bowlero (BOWL), American Water Works (AWK), Estee Lauder (EL), and Salesforce (CRM). Soros increased its stake in 20 holdings, including by size of previous position, Amazon (AMZN), AerCap (AER), Alphabet (GOOGL), Rivian (RIVN), and Aptiv (APTV). Soros reduced its stake in 20 holdings, including by size of previous position, Figs (FIGS), LPL Financial (LPLA), Indie Semiconductor (INDI), Fastly (FSLY), and Qualcomm (QCOM). Soros' top holdings as of June 30, in order of size, were Horizon Therapeutics (HZNP), Alphabet, Liberty Broadband (LBRDK), and Amazon.
|
AMC | Hot Stocks10:20 EDT AMC announces 10-for-1 reverse stock split effective August 24 - AMC Entertainment said it filed an amendment to increase the total number of authorized shares of the company's class A common stock from 524,173,073 to 550,000,000 shares of common stock and effectuate a reverse stock split at a ratio of one share of class A common stock for every ten shares of class A common stock, in each case, effective as of August 24. The reverse stock Split together with the share increase will permit the conversion of all of the company's outstanding AMC preferred equity units, known as "APEs," into shares of class A common stock. The company expects the APEs to cease trading on August 25 and subsequently be delisted from the New York Stock Exchange. Shares of AMC are down 37% to $3.32 in early trading.
|
MRNA | Hot Stocks10:05 EDT UMass Chan Medical School to begin enrolling study on CMV transmission - UMass Chan Medical School will begin enrolling participants at group child care and early childhood education settings in Worcester and Cambridge to examine the impact of cytomegalovirus transmission. The study is a collaboration with Moderna, which is currently researching a vaccine for CMV. The study will examine how CMV spreads among children and between household members. The study, called CMV Transmission and Immune Tracking, will examine how CMV spreads among children and between household members, with an aim to characterize immune responses to CMV infection over time. Findings from the study will inform the design of CMV prevention strategies, including awareness campaigns for CMV, to potentially reduce its spread in similar group settings. CMV is the most common infectious cause of birth defects in the world. The virus can spread from pregnant women to their unborn children, a condition known as congenital CMV infection. Infants with cCMV at birth are at risk for abnormal neurodevelopment, including hearing loss and microcephaly. Overall, nearly 20 percent of infants with cCMV have long-term effects from the virus. The study is led by Laura Gibson, MD'94, associate professor of medicine at UMass Chan. Dr. Gibson has extensive expertise in congenital CMV infection, including studies of T-cell responses to CMV in children. Participation in the study involves having the parent or guardian of the participant child complete an online eligibility assessment and survey about the child and their household, as well as having the child provide a saliva sample. The study team appointed a Community Advisory Board to offer expertise in the areas of childcare, occupational safety and research, while also including community members, center parents and parents who have been affected by CMV. Through building relationships within the communities, the study team has already built a network of public and private licensed day care centers to participate in the study, including the YWCA of Central Massachusetts, which also participates on the Community Advisory Board.
|
VZ | Hot Stocks10:02 EDT Verizon, LALIGA North America renew partnership for three more seasons - LALIGA North America announced the renewal of a multi-year partnership with Verizon, exclusive to the United States. This multifaceted partnership will offer Verizon customers the chance to interact with one of the best soccer leagues in the world through coast-to-coast watch parties, once-in-a-lifetime experiences at LALIGA matches in Spain and the LALIGA Summer Tour in the U.S., and other experiences with LALIGA players and Ambassadors. With this expanded, multi-year partnership, Verizon will continue to leverage LALIGA's distinguished IP and access its coveted, diverse, and highly engaged audience that is rapidly expanding.
|
BMA | Hot Stocks10:00 EDT Banco Macro falls -13.3% - Banco Macro is down -13.3%, or -$3.39 to $22.13.
|
AMC | Hot Stocks10:00 EDT AMC Entertainment falls -38.0% - AMC Entertainment is down -38.0%, or -$2.00 to $3.26.
|
HE | Hot Stocks10:00 EDT Hawaiian Electric falls -39.3% - Hawaiian Electric is down -39.3%, or -$12.72 to $19.68.
|
ACHR | Hot Stocks10:00 EDT Archer Aviation rises 8.2% - Archer Aviation is up 8.2%, or 47c to $6.25.
|
IRRX | Hot Stocks10:00 EDT Integrated Rail and Resources Acquisition rises 10.0% - Integrated Rail and Resources Acquisition is up 10.0%, or $1.07 to $11.81.
|
X | Hot Stocks10:00 EDT U.S. Steel rises 25.0% - U.S. Steel is up 25.0%, or $5.69 to $28.41.
|
PNAC | Hot Stocks09:52 EDT PNAC Stock trading resumes
|
NKLA | Hot Stocks09:51 EDT Nikola sinks after battery-electric vehicle recall, hold on sales - Nikola on Friday night provides the preliminary results of its battery pack investigations and as a "precautionary measure," announced a voluntary recall of approximately 209 Class 8 Tre battery-electric vehicles. Nikola is currently in the process of filing this voluntary recall with the National Highway Traffic Safety Administration and is placing a temporary hold on new BEV sales until a resolution is in place. The actions do not affect the hydrogen fuel cell electric vehicle currently in production as the truck's battery pack has a different design. Following an August 10 presentation of preliminary findings from Exponent, a third-party investigator, a coolant leak inside a single battery pack was found to be the probable cause of the truck fire at the company's headquarters in Phoenix, Ariz. on June 23, Nikola said in a statement. The findings were further corroborated by a minor thermal incident that impacted one pack on an engineering validation truck parked at the company's Coolidge, Ariz. plant on Aug. 10. No one was injured in either incident, it added. "The company's initial statement on June 23 alluded to foul play as a possible cause of the incident, based on video footage showing a vehicle parked next to the impacted trucks and quickly pulling away after a bright flash and the commencement of the fire. Extensive internal and third party-led hypothesis testing, employee and contractor interviews, and hours of video footage review has since suggested foul play or other external factors were unlikely to have caused the incident," Nikola said. The stock in early trading is down 10% to $1.76.
|
PERF | Hot Stocks09:47 EDT Perfect Corp. falls -8.9% - Perfect Corp. is down -8.9%, or -39c to $4.00.
|
AMC | Hot Stocks09:47 EDT AMC Entertainment falls -33.2% - AMC Entertainment is down -33.2%, or -$1.75 to $3.52.
|
HE | Hot Stocks09:47 EDT Hawaiian Electric falls -39.5% - Hawaiian Electric is down -39.5%, or -$12.81 to $19.59.
|
OUST | Hot Stocks09:47 EDT Ouster rises 6.4% - Ouster is up 6.4%, or 42c to $7.03.
|
HRTG | Hot Stocks09:47 EDT Heritage Insurance rises 6.7% - Heritage Insurance is up 6.7%, or 35c to $5.60.
|
X | Hot Stocks09:47 EDT U.S. Steel rises 27.0% - U.S. Steel is up 27.0%, or $6.13 to $28.85.
|
HE | Hot Stocks09:43 EDT Hawaiian Electric says over 60% of customers brought back online - Hawaiian Electric on Sunday said its restoration crews have brought back online more than 60% of customers who have been without electricity since Tuesday and are continuing work to restore approximately 5,000 customers in West Maui and Upcountry. The customer outage count has not been adjusted downward to account for structures that have been damaged or destroyed. "Because there has been a tremendous amount of damage to the system at the distribution and substation level - these are the parts of the system that deliver electricity to communities and neighborhood - the system is still fragile, and the restoration must be done carefully to, above all, ensure the safety of the public and our workers," the company said in a statement. Reference Link
|
PNAC | Hot Stocks09:42 EDT PNAC Stock trading halted, volatility trading pause
|
BTAI | Hot Stocks09:40 EDT BioXcel Therapeutics trading resumes
|
HE | Hot Stocks09:35 EDT Hawaiian Electric sinks 40% on possible ties to Maui fires - Shares of Hawaiian Electric are sinking following the deadly wildfires in Maui, Hawaii. Hawaiian Electric operates the utility that serves Maui and has come under criticism for not turning off power despite warnings that dry, gusty winds could create critical fire conditions. Plaintiffs attorneys are homing in on the utility's equipment as a possible source of ignition and plan to file lawsuits this week, according to Bloomberg. Shares of Hawaiian Electric are down 40% to $19.36 in early trading.
|
BTAI | Hot Stocks09:35 EDT BioXcel Therapeutics trading halted, volatility trading pause
|
CNVS | Hot Stocks09:33 EDT Cineverse enters agreement with Philo for Fandor service - Cineverse announced that, through a new agreement with Philo, its Fandor streaming service is now available to subscribers of Philo's "Movies & More" package.
|
EPOW | Hot Stocks09:26 EDT Sunrise New Energy factory passes inspection - Sunrise New Energy announced that Sunrise New Energy Materials Co., Ltd. has passed rigorous and detailed on-site inspection by CATL and started monthly bulk delivery on August 8. CATL is the largest volume EV battery manufacturer in the world and also builds lithium-ion batteries for use in energy storage and commercial applications. CATL trades on the Shenzhen Stock Exchange and has a market capitalization of over $141 billion and annual sales exceeding $45 billion. CATL has rigorous inspection procedures for suppliers, and it has assigned experts on site for months at Sunrise's manufacturing plant in Guizhou Province. These experts investigated the manufacturing methods and quality control as well as tested the finished product of Sunrise on an ongoing basis and has given the Company top marks on the assessment. The Company has shipped 30 tons of graphite anode to CATL last week, and it will provide 80,000 tons of products to CATL over the next two years.
|
HRYU | Hot Stocks09:24 EDT Hanryu Holdings partners with SALTLUX for virtual assistant development - Hanryu Holdings has partnered with SALTLUX to incorporate AI-powered technology into the Company's popular global fandom application, FANTOO. Hanryu Holdings will incorporate SALTLUX's AI-powered conversational virtual assistant to enhance user engagement with Talkbot, an intelligent chatbot, onto the FANTOO application. Hanryu Holdings plans to apply their and SALTLUX's technologies to the upcoming personalized AI assistant service. Deok Gom, FANTOO's virtual assistant, is a representative character of FANTOO whose name means to be passionate about something. The service is scheduled to be launched within this year and will include personal AI and Club AI, offering customized services based on user personality and lifestyle analysis.
|
LPLA | Hot Stocks09:23 EDT LPL Financial welcomes financial advisors Schuler, Gibson - LPL Financial announced that financial advisors Colleen Schuler, MBA, CFP and John Gibson, CFP have joined LPL Financial's broker-dealer, RIA and custodial platforms. They reported having served approximately $205M in advisory, brokerage and retirement plan assets, and join LPL from Fulton Financial Advisors, part of Raymond James. Looking to pair their client-centered philosophy with a desire for more autonomy, the team interviewed several wealth management firms before selecting LPL Financial as the best fit for their business.
|
GIPR | Hot Stocks09:22 EDT Generation Income Properties completes acquisition of property portfolio - Generation Income Properties announced the closing of a 13-property portfolio for total consideration of $42 million on August 10, 2023. The portfolio consists of eleven retail properties and two office properties, and approximately 76% of the annualized base rent attributable to the portfolio is derived from tenants who have an investment grade credit rating from a recognized credit rating agency of "BBB-" or better. The portfolio has a weighted average remaining lease term of approximately 5.6 years, is approximately 202,000 square feet and 100% occupied. The transaction increases GIPR's geographic footprint from eight to thirteen states and increases the total number of properties owned to twenty-six, including one property owned in a tenant-in-common structure. The purchase price for the portfolio was $42 million, excluding estimated transaction costs and expenses of $1.6 million, consisting of $30 million paid in cash and $12 million paid in shares of a newly issued series of preferred stock of GIPR designated as "Series A Redeemable Preferred Stock." The cash portion of the purchase price was financed with a combination of cash on hand, a new $21.0 million secured debt facility and a $12 million preferred equity investment in a special purpose subsidiary of GIPR's operating partnership. The preferred equity investment was led by real estate private equity firm, Loci Capital.
|
MDGS PRZO | Hot Stocks09:22 EDT Medigus announces ParaZero has announced release of SafeAir M350 Pro - Medigus (MDGS) announced that ParaZero Technologies (PRZO) has announced the official release of the SafeAir M350 Pro, a parachute system designed for DJI's newest enterprise drone, DJI M350 RTK. ParaZero's SafeAir M350 Pro is a drone parachute recovery system that mitigates flight risks autonomously. The SafeAir system is equipped with integrated sensors that continuously monitor and analyze the drone's flight patterns to identify any indications of a critical failure. When triggered, the SmartAir Pro, ParaZero's onboard computer, responds with an instantaneous activation of the SafeAir system. The system cuts power to the drone, alerts people on the ground with an audible alarm, and deploys a lightweight parachute, bringing the drone to the ground in a safe, controlled descent.
|
PYPL INTU | Hot Stocks09:21 EDT PayPal names Alex Chriss as next President and CEO - PayPal (PYPL) announced that its Board of Directors has appointed senior Intuit (INTU) executive, Alex Chriss, as President and CEO, effective September 27. Chriss will also join the Board on that date. The appointment follows a thorough CEO search process, conducted by the Board over the last number of months, with the mandate to appoint a next generation leader with extensive global payments, product, and technology experience, capable of driving growth across the PayPal platform for years to come. Chriss has the unanimous support of the Board and its CEO search committee following extensive engagement and evaluation across all of the key metrics that are critical to PayPal's future success. Schulman will remain on the board of the company until its next annual meeting of stockholders in May 2024.
|
EFSH | Hot Stocks09:21 EDT 1847 Holdings secures additional unsecured debt financing - 1847 Holdings has closed an unsecured debt financing with certain institutional and other accredited investors. The Company issued to the Investors 20% OID subordinated promissory notes in the aggregate principal amount of $3,125,000 and warrants for the purchase of an aggregate of 4,098,361 common shares for a total purchase price of $2,500,000 in a private placement transaction.
|
TOMZ PFE | Hot Stocks09:20 EDT Pfizer Rocky Mount turn to SteraMist for post-tornado decontamination - TOMI Environmental Solutions (TOMZ) announces that Pfizer Rocky Mount (PFE) has engaged TOMI's iHP Corporate Service to conduct emergency decontamination within their facility, which suffered substantial damage due to a recent tornado. Pfizer Rocky Mount has been a long-term, loyal client of TOMI, having commenced their utilization of SteraMist iHP Corporate Service in 2014. Since then, TOMI has been performing decontamination service twice a year during their facility's routine scheduled shutdowns and called on as necessary throughout the years.
|
NBTB SAL | Hot Stocks09:18 EDT NBT Bancorp completes merger with Salisbury Bancorp - NBT Bancorp (NBTB) announced that it completed the merger of Salisbury Bancorp (SAL) with and into NBT on August 11, 2023. The Merger added 13 banking offices to the NBT franchise in complementary markets, including northwestern Connecticut, the Hudson Valley region of New York and southwestern Massachusetts. Following a core systems conversion that occurred over the weekend, NBT Bank now has 153 banking offices across its seven-state footprint. "We are honored to build on the relationships Salisbury has cultivated with its customers, communities and shareholders for 175 years," said NBT President and CEO John H. Watt, Jr. "We are also pleased to welcome the dedicated professionals joining NBT in customer-facing positions in our retail, commercial and wealth management businesses along with many in key support roles in our new Lakeville Operations Center. With the integration of our two high-quality community banks, we are focused on continuing to support all stakeholders with a smooth transition and to the opportunity to grow our combined company together." In connection with the closing of the Merger, NBT has appointed former President and CEO of Salisbury, Richard Cantele, Jr., to its board of directors. He will also join the Executive Management Team at NBT.
|
NBTB | Hot Stocks09:18 EDT NBT Bancorp increases quarterly dividend 6.7% to 32c per share - On August 14, 2023, NBT approved a third-quarter 2023 cash dividend of $0.32 per share, which represents a $0.02 per quarter, or 6.7%, increase over the dividend paid in the second quarter of this year. This is the Company's eleventh consecutive year of annual dividend increases. The dividend will be paid on September 15, 2023 to shareholders of record on September 1, 2023.
|
CNSP | Hot Stocks09:17 EDT CNS Pharmaceuticals presents updated results from berubicin study - CNS Pharmaceuticals announced the presentation of updated results from the on-going potentially pivotal study evaluating Berubicin, the Company's novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier, in a poster presentation at the 2023 SNO/ASCO CNS Cancer Conference, held August 10-12, 2023 in San Francisco, CA. The poster, titled, "A randomized, controlled trial of Berubicin, a topoisomerase II poison that appears to cross the blood-brain barrier, after first-line therapy for glioblastoma multiforme: Preliminary Results," was presented by Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals. The presented poster is now available on the Company's website. As of the data cutoff for the poster, 151 patients had been enrolled, 105 on Berubicin and 46 on Lomustine. Enrolled patients received 7.5 mg/m2/day of intravenous Berubicin over 2 hours for 3 consecutive days every 21 days. Previous results from this study were presented in November 2022 at the Society for Neuro-Oncology 27th Annual Meeting. Summary of Updated Results from the Potentially Pivotal Study: All patients enrolled show comparable demographics for each arm, including age, gender, race, BSA, and KPS. In addition, patients have been stratified by MGMT methylation, allowing a reasonable comparison of efficacy based on this prognostic feature between the two groups. The unmethylated MGMT population comprises approximately 38% of all enrolled patients. Approximately 50% of patients on both arms have completed the study, i.e. have participated in an end of treatment visit, and withdrawal prior to EOT is relatively small, although almost twice the percent of patients in the Lomustine group compared to Berubicin have withdrawn. Primary reasons for withdrawal across both arms include Adverse Events, Physician Decision, Withdrawal by Patient, and Death as well as Other nonspecified reasons. All grades of adverse events occurring in more than 10% of patients, as well as Grade 3-5 events, are presented in the poster, with the overall percentages similar in the Berubicin and Lomustine arms. In terms of myelosuppression, neutrophil, and red blood cell count [anemia] reductions are also similar however thrombocytopenia seems to be higher in the Lomustine arm. The primary endpoint of the study is Overall Survival, a rigorous endpoint that the FDA has recognized as the basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm. CNS Pharmaceuticals recently announced it has now reached the criteria required by the study protocol to conduct a pre-planned, non-binding futility analysis, which an independent Data Safety Monitoring Board will review to determine whether to recommend continuing the study as planned or modifying the study based on Berubicin showing potential value as a second-line treatment for patients with glioblastoma. CNS Pharmaceuticals previously reported that the Company would conduct this analysis after at least 50% of the patients in the population to be analyzed for the interim analysis had reached the primary efficacy endpoint, as provided for in the study protocol. The DSMB will review the number of deaths in each arm to ensure that the overall survival of patients receiving Berubicin shows at least a statistically significant comparability to those receiving Lomustine. Additional analyses will include comparisons of secondary endpoints, including progression-free survival, response rates, and safety assessments. The Company is confident it will announce the results from the interim analysis publicly before the year end. Enrollment will continue during the interim analysis.
|
STIM | Hot Stocks09:16 EDT Neuronetics announces enhancements to TrakStar Patient Data Management - Neuronetics announced enhancements to the TrakStar Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting system for NeuroStar transcranial magnetic stimulation, TMS, providers. The update introduces a range of automated features to improve communication between providers and their existing and prospective patients, while also saving practices time in recording and documenting results. "Our providers do vital work helping patients with drug-resistant depression and other conditions, and our commitment lies in making TrakStar an indispensable part of their practice," stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. "The enhancements we've made to our industry-defining TrakStar system allow practices to continue to elevate the standard of patient care they provide. With the latest updates, NeuroStar providers can more easily connect with their patients using automated SMS text messaging, a new avenue for communication that can save practices time and support patients through their treatment process."
|
EHAB | Hot Stocks09:15 EDT AREX Capital Management issues letter to board of directors of Enhabit - AREX Capital Management, LP, together with its affiliates, the owners of approximately 4.7% of the shares of Enhabit, issued an open letter to the Company's Board of Directors. "We were pleased that the Company announced last week that it intends to launch a strategic alternatives process upon receiving a tax opinion that such action would not jeopardize the tax-free treatment of Enhabit's spin-off. Based on our extensive discussions with tax counsel and our experience investing in spin-offs, we are confident that this opinion can be obtained promptly... We were simultaneously disappointed by Enhabit's second quarter performance and revised 2023 outlook. In addition to the issues that the Company has been encountering operationally, we were again struck by the magnitude of its unallocated home office expenses, which are now roughly equivalent to its overall EBITDA guidance... Shareholders must have full confidence in Enhabit's Board of Directors to conduct a fulsome, robust, and value-maximizing strategic alternatives process. Candidly, we do not believe that the Board, as currently constituted, enjoys such confidence... In the same vein, we were disappointed when the Company recently informed us that it would not be accepting either of our proposed directors, and that it did not anticipate adding any in the near future... The Company is correct that there should be no net additions to its Board, as Enhabit already carries a bloated home office cost burden and has too many directors for a company of its size. However, in light of shareholder apprehension concerning the Board as well as the Company's commitment to replace at least four of the legacy Encompass directors by the 2024 Annual Meeting of Stockholders, we are shocked by the Board's unwillingness to accelerate its transition by adding two directors who would contribute valuable operational perspective during the strategic alternatives process. As the Company embarks upon this critical journey to realize Enhabit's considerable strategic value, we believe that the Company should take steps to bolster shareholder confidence in the Board... In closing, we applaud the Board's decision to initiate a strategic alternatives process, and we are confident that Enhabit's strategic value significantly exceeds its current valuation... It seems to us that the only way that shareholders might not realize this strategic value would be if the process were not conducted in an appropriate and sincere manner. If this happens, and if the process fails to yield the proper outcome for shareholders, we will review all options at our disposal to ensure that the Board is held accountable."
|
VRAR | Hot Stocks09:14 EDT Glimpse Group' PulpoAR enters license agreement for SkinAI solution - The Glimpse Group that its subsidiary company, PulpoAR has entered into a software license agreement for its SkinAI solution with Yves Rocher, a global skin care, cosmetics and perfume company. As part of this initial software license agreement, valued in the mid five figures, PulpoAR will provide Yves Rocher with the ability to integrate more than 100 of its beauty product SKUs on the SkinAI software, which could translate in hundreds of thousands online diagnostics per month.
|
RMED | Hot Stocks09:12 EDT Ra Medical Systems receives notice of allowance for patent - Ra Medical Systems received notification of allowance of the first patent to be issued for the company's LockeT product. Entitled "Vessel Closing Device", the patent to be granted is one in a family of six patent applications on file in the US, and in a number of foreign countries, including the European Community, Japan, and China. This new patent will join the company's library of over fifty patents and patent applications on the company's three cardiology technologies.
|
BLNK | Hot Stocks09:12 EDT Blink Charging announces installation of eight new EV charging stations - Blink Charging has announced the installation of eight new EV charging stations at the Columbia Center Tower in Seattle, Washington, the tallest office tower in the state, to bring additional convenient and reliable EV charging to tenants and visitors. "Blink is proud to continue and expand our service to Columbia Center Tower. We commend their forward-thinking approach to enhance EV charging accessibility at this incredible property," said Mike Battaglia, Chief Revenue Officer for Blink Charging. "Providing EV charging stations in the workplace is crucial for advancing and adopting EVs everywhere and we hope other property owners and managers will view them as positive example."
|
MGRM | Hot Stocks09:12 EDT Monogram Orthopaedics completes development phase of surgical robotic system - Monogram Orthopaedics announced the completion of the Development Phase and the start of the Verification Phase for the Company's next-generation autonomous surgical robotic system, a key milestone in Monogram's commercialization journey. The development cycle for medical devices involves several phases to ensure their effective and safe production, including Conceptualization, Feasibility Studies, Design and Development, Verification, Validation, Regulatory Approval and Clinical Evaluation, and Manufacturing and Commercialization. During the Verification phase, Monogram will rigorously test and validate its autonomous surgical robotics and related software to ensure the required design specifications, functionality, standards, and quality under different conditions and scenarios are met before surgeons use the product in the operating room on patients. The team will perform extensive tests and evaluations to ensure the product performs as intended. Any identified issues will be addressed and rectified before moving forward. After completing the Verification phase, the Company expects to enter the Validation phase to validate that the technology meets end-users' and customers' needs and expectations. The Validation phase will assess the product's overall usability and appropriateness in real-world scenarios, including surgeons running simulated surgeries on cadavers and evaluating iatrogenic injury and general product performance. Monogram has now filed over 20 patent applications related to various aspects of autonomous robotic execution, custom implants and novel tracking methods. It aims to be the first autonomous system on the market to utilize a robot-mounted sagittal saw. In March 2023, Monogram made history with the first fully remote simulated robotic surgery.
|
CLRB | Hot Stocks09:12 EDT Cellectar Biosciences expects cash to fund operations into Q4 of 2023 - As of June 30, 2023, the company had cash and cash equivalents of $5.2 million, compared to $19.9 million as of December 31, 2022. Net cash used in operating activities during the three months ended June 30, 2023 was approximately $7.5 million. The company believes its cash on hand is adequate to fund budgeted operations into the fourth quarter of 2023.
|
GSL | Hot Stocks09:11 EDT Global Ship management discuss corporate developments, container shipping - Capital Link President Nicolas Bornozis recently hosted an interview with members of the senior management team of Global Ship Lease, Ian Webber, Chief Executive Officer, Thomas Lister, Chief Commercial Officer & Head of ESG, and Tassos Psaropoulos, Chief Financial Officer. The interview, part of Capital Link's "Trending News Podcast Series," touched upon the company's recently announced Q2 2023 results, with a focus on GSL's development, strategy, and container shipping sector outlook.
|
RNVA | Hot Stocks09:10 EDT Rennova Health announces opening of its first treatment facility - Rennova Health announces that its behavioral health services subsidiary, Myrtle Recovery Centers, has been granted a license under the rules of the Department of Mental Health and Substance Abuse Services of the State of Tennessee to operate an alcohol and drug treatment facility in Oneida, Tennessee. The facility, located at Rennova's Big South Fork Medical Center campus, will commence operations and begin accepting patients today. The facility will offer alcohol and drug residential detoxification and residential rehabilitation treatment services to up to 30 patients. Myrtle intends to offer office-based opioid treatment as outpatient treatment services at Oneida in the future. "We are delighted to open this first facility for Myrtle," stated Seamus Lagan, Chief Executive Officer of Rennova Health, Inc. "We believe Myrtle is a complementary business model to our current rural healthcare services offerings and an excellent use of available space at our rural, critical access hospital. We look forward to this new subsidiary generating additional revenues for the Company and considering our options to expand this business."
|
LLY | Hot Stocks09:10 EDT Eli Lilly completes acquisition of Versanis Bio - Eli Lilly and Company announced the successful completion of its acquisition of Versanis Bio. The acquisition expands Lilly's portfolio to include Versanis' lead asset, bimagrumab, which is currently being assessed in a Phase 2b study alone and in combination with semaglutide in adults living with overweight or obesity. Under the terms of the agreement, Versanis shareholders could receive up to $1.925B in cash, inclusive of the upfront payment and subsequent payments upon achievement of certain development and sales milestones.
|
YVR | Hot Stocks09:09 EDT Liquid Media receives non-binding term sheet from fast-growing company - Liquid Media Group announced that it has received a non-binding term sheet, LOI, in respect of a proposed restructuring transaction from a fast-growing, category-leading company that has attracted top-tier investor interest and demonstrated strong revenue scaling over the previous two years. Under the terms of the LOI, the Target would merge with a wholly-owned subsidiary of the Company in a stock-for-stock reverse merger transaction in which the Target will survive as a wholly-owned subsidiary of Liquid. Should the Company determine to proceed with the Merger, the Company would commence immediate efforts to evaluate potential strategic alternatives for its existing assets, including but not limited to, strategic sale, spin-off, or keeping them in place at the Company. Under the terms of the LOI, the Company would retain 25% of the post-merger entity, and the shareholders of the Target would own 75%. The Company is currently subject to a cease trade order, CTO, issued by the British Columbia Securities Commission under National Instrument 51-102 - Continuous Disclosure Obligations as a result of the Company not having filed its annual financial statements and accompanying management's discussion and analysis, annual information form and related certifications for the fiscal year ended November 30, 2022. The Company will not accept the LOI, nor pursue the Merger, until the CTO has been revoked. The Company will provide further updates in this regard in due course.
|
FTDR | Hot Stocks09:07 EDT Frontdoor announces Frontdoor app surpasses one million downloads - Frontdoor announced that the Frontdoor app has been downloaded over one million times since it was launched April 11. "Consumer awareness of the app has been through the roof," said Bill Cobb, Frontdoor's Chairman & CEO. "And with a great offer on our most comprehensive plan, Frontdoor Premium, we expect this trend to continue." Frontdoor Premium is the service plan for the homeowner who wants it all. "Coverage for repairs, real-time video chat for advice from an Expert, and repair or maintenance services performed by Pros who have been vetted by Frontdoor," Cobb said. "You'll also get access to steep discounts on a new HVAC system. Many parts of the country continue to see extreme temperatures and this membership perk alone can save you thousands of dollars."
|
SGPYY | Hot Stocks09:07 EDT Sage Group partners with Mamava for breastfeeding accessability - Sage announced a partnership with Mamava. By partnering during National Breastfeeding Month, Sage and Mamava are breaking down barriers while making good business sense in communities throughout the US. As a growing business, the company can rely on their new enterprise resource planner solution to assist in overhauling systems and processes to make their financials flow. The Sage X3 comprehensive software suite drives digital transformation for growing companies with data flow to streamline all business operations.
|
ASNS | Hot Stocks09:06 EDT U.S. Air Force selects Actelis Networks for IoT networking modernization - Actelis Networks was recently selected by the United States Air Force to modernize on-base networking. The Company's hybrid fiber-copper networking solutions will extend connectivity to 41 sites within the base, enabling data services as well as monitoring and control for mission critical systems.
|
ARCT | Hot Stocks09:06 EDT Arcturus JV mRNA manufacturing partner, ARCALIS, awarded $115M in Japan grants - Arcturus Therapeutics Holdings announced that ARCALIS , its manufacturing joint venture in Japan to support the production of mRNA vaccines and therapeutics, has been awarded $115M in two separate grants from the Japanese government. The grants will be used to fund the construction of a factory and the purchase of capital equipment to support current Good Manufacturing Practice cGMP production of mRNA drug substance and mRNA drug product operations. Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115M in Grants from the Japanese Government .ARCALIS is a joint venture between Axcelead and Arcturus, wherein Arcturus holds a 49% equity position that is subject to dilution. The factory, located in Minamisoma City, Japan, is designed to provide cGMP integrated vaccine manufacturing, from mRNA drug substance to bulk nanoparticle-formulated drug product.
|
SCWX | Hot Stocks09:04 EDT Secureworks announces 15% workforce reduction - On August 4, SecureWorks committed to, and on August 14, announced to employees, a plan to reduce the company's workforce by approximately 15% and to implement certain real estate-related cost optimization actions. Under the Plan, the company intends to rebalance investments cross-functionally in alignment with the company's current strategy and growth opportunities, such as focusing on the higher value, higher margin Taegis solutions, optimizing the company's organizational structure to increase its scalability, and other priorities, to better position the company for continued growth with improving operating margins over time. In connection with the Plan, the company currently estimates that it will incur expenses up to approximately $14.2M, the substantial majority of which are expected to result in future cash expenditures. These expenses are anticipated to consist primarily of severance and other termination benefits, as well as real estate-related expenses. The company expects to recognize these anticipated expenses during the second quarter of fiscal year 2024 and to substantially complete the Plan during the third quarter of fiscal year 2024, although the timing of workforce reductions may vary by country based on local requirements.
|
KHC | Hot Stocks09:04 EDT Kraft Heinz CEO Miguel Patricio to switch roles, Carlos Abrams-Rivera to succeed - Kraft Heinz announced that the company's board of directors has appointed Carlos Abrams-Rivera as CEO and a member of the board, effective January 1, 2024. Until then, Abrams-Rivera will continue in his role as president of the North America Zone with the added responsibilities of becoming president of Kraft Heinz, effective immediately. Abrams-Rivera will take over as CEO from Miguel Patricio, who has served as the company's CEO since 2019 and chair of the board since 2022. Patricio will transition to the role of non-executive chair of the board on January 1, 2024. Patricio will transition to a new role as non-executive chair of the board.
|
GVP | Hot Stocks09:04 EDT GSE Systems wins recent simulation awards worth $4M - GSE Systems announced two major simulation solution wins valued in excess of $4M. The recent awards include: $2.5M to upgrade and integrate plant simulation models for a large, advanced reactor to reflect final "as built" designs. GSE has been part of this customer's integration team and simulation platform since 2008. This win is an extension of that award. A $1.5M award to qualify and deliver a software-based reactor coolant system to support thermohydraulic models for a large international power industry supplier.
|
AENT | Hot Stocks09:03 EDT Alliance Entertainment's AMPED distribution celebrates 20 award nominations - Alliance Entertainment announced that its independent distribution arm AMPED Distribution, a leading force in the bluegrass music industry with an exceptional roster of artists and labels, has received a remarkable 20 nominations at the 2023 International Bluegrass Music Awards. "These nominations stand as a testament to the extraordinary talent and unwavering dedication within the genre, further solidifying AMPED Distribution's commitment to supporting and promoting the very best in bluegrass music," the company said.
|
AJG | Hot Stocks09:02 EDT Arthur J. Gallagher acquires Toronto-based Horn and Associates - Arthur J. Gallagher acquired Toronto, Ontario-based A.H. Horn and Associates, dba Horn. Terms of the transaction were not disclosed. Horn provides sales and leadership development programs and consulting services across a variety of industries globally. The Horn team will operate under the direction of Sarah Beech, head of Gallagher's benefits and HR consulting operation in Canada.
|
ASGOF | Hot Stocks09:02 EDT Asante Gold appoints David Wiens as CFO - Asante Gold announces the formal appointment of David Wiens as CFO. We also want to thank and recognize Mr. Dindiok Chialin, who has served as Interim CFO since early June 2023. Dindiok is the Asante Gold Deputy CFO. He was most recently Chief Financial Officer of Bunker Hill Mining Corp.,
|
GDNSF | Hot Stocks09:01 EDT Goodness Growth expands Maryland retail presence - Goodness Growth announced that it has entered into consulting, licensing and wholesale agreements with two additional dispensaries in Maryland that are owned and controlled by HA-MD LLC and currently operate under the Ethos brand name. The agreements will result in the two Ethos dispensaries in Hampden and Rockville being, upon regulatory approval, rebranded to Green Goods and include an option to acquire the two dispensaries if and when allowed by applicable law and regulations. Interim Chief Executive Officer Josh Rosen commented, "We are pleased to lean into our team's capabilities and to expand our reach in the Maryland market, while also adding two more retail dispensaries under the Green Goods(R) brand. In recent quarters we have improved the quality and depth of our product offerings in Maryland, and these agreements provide an opportunity for us to expand our revenue, cash flow and market presence. We are also pleased with the future potential to acquire these stores when the law and regulations allow, which gives us the potential to reach the retail license limit of four stores in Maryland's adult-use market."
|
ALLO AMTI | Hot Stocks09:00 EDT Allogene Therapeutics appoints Douglas as General Counsel - Allogene Therapeutics (ALLO) announced that Earl Douglas has been appointed as General Counsel. Douglas will oversee all aspects of the Company's legal function and serve as a member of the Leadership Team. Prior to Allogene, Douglas served as General Counsel for Applied Molecular Transport (AMTI), a clinical-stage biopharmaceutical company.
|
BNIX | Hot Stocks09:00 EDT Bannix Acquisition announces monthly extension to complete business combination - Bannix Acquisition board of directors has decided to extend the date by which Bannix must consummate an initial business combination from August 14, 2023 for an additional month, to September 14, 2023. As previously disclosed, at a special meeting of its stockholders held on March 8, 2023, Bannix' stockholders voted in favor of a proposal to amend Bannix's Amended and Restated Certificate of Incorporation to provide Bannix with the right to extend the Deadline Date up to 12 times for an additional one month each time until March 14, 2024. On March 9, 2023, Bannix filed the Amended Charter with the Secretary of State of the State of Delaware. Also as previously announced, if an Extension is implemented, the sponsor of Bannix, Instant Fame, or its designees will deposit into the trust account, as a loan, the lesser of $75,000 and $0.07 for each share that is not redeemed in connection with the special meeting. On August 14, 2023, the Board, at the request of the Sponsor, decided to implement a sixth Extension and to extend the Deadline Date for an additional month to September 14, 2023.
|
MOND | Hot Stocks08:59 EDT Mondee announces acquisition of Skypass Travel - Mondee announced the acquisition of Skypass Travel, a global full-service retail and wholesale provider of corporate, leisure, and humanitarian travel, based in the Dallas, Texas area. The acquisition of Skypass supports Mondee's ongoing expansion and diversification endeavors, encompassing markets that serve both personnel and affiliates from international corporations, small and midsize businesses, as well as humanitarian organizations. Skypass maintains domestic offices in the Dallas, Texas area and Austin, Texas. Furthermore, it boasts a global footprint through its international offices located in Latin America, Mexico, Canada, and India. Skypass achieved a gross revenue of $45 million and adjusted EBITDA of $4 million, representing a margin on net revenue of approximately 60%, in 2022. At closing, Mondee paid a consideration of approximately $15 million, comprised of cash and Mondee common stock priced at $10 per share. Following the successful acquisitions of Consolid, Orinter and Interep, Mondee is poised to strategically advance the distribution of Skypass's travel-related offerings. Mondee's Founder, Chairman, and CEO, Prasad Gundumogula, stated, "We are thrilled to extend a warm welcome to Victor Abraham, CEO of Skypass, and his experienced management team as valued members of the Mondee family and look forward to helping provide their customers with access to our AI-Powered Travel Marketplace, as well as additional products and services. We have every confidence they will continue to grow the business actively within their served markets. This acquisition underscores our commitment to diversifying our distribution to SMBs and international corporate accounts along with geographical expansion into India, Mexico, and LATAM."
|
ABL | Hot Stocks08:58 EDT Abacus Life appoints Seth Miller as CRO - Abacus Life announced that Seth Miller has been appointed as Chief Revenue Officer to continue to drive relationships with life insurance carriers and wealth management institutions. Miller brings 25 years of leadership experience in financial services distribution and manufacturing and previously served in senior roles for World Financial Group. As Chief Revenue Officer at Abacus, Miller will focus on relationship-building with the goal of partnering with insurance carriers and institutions and driving awareness of Abacus' offerings.
|
SAR | Hot Stocks08:57 EDT Saratoga Investment increases quarterly dividend 1c to 71c per share - Saratoga Investment announced that its Board of Directors has declared a quarterly dividend of 71c per share for the fiscal second quarter ended August 31, 2023, an increase of $0.01 from $0.70 per share in the prior fiscal first quarter, and the fourteenth quarterly dividend increase in a row. This dividend is payable on September 28, 2023, to all stockholders of record at the close of business on September 14, 2023. "The impact of the absolute level and continued increase in interest rates on our largely floating rate assets, when combined with the growth of our overall portfolio, its resilient performance and our largely fixed rate liabilities, have resulted in record earnings," said Christian L. Oberbeck, Chairman and Chief Executive Officer of Saratoga Investment. "Saratoga's second quarter dividend of 71c per share reflects an approximately 31% increase year-over-year. Annualizing this dividend rate, coupled with our last reported record quarterly adjusted net investment income of $1.08 per share, imply a 10.7% dividend yield, and importantly, a 16.3% earnings yield based on Saratoga's recent stock price of $26.57 per share on August 11, 2023."
|
SLNA | Hot Stocks08:57 EDT Selina Hospitality expands to Mediterranean with location in Evia, Greece - Selina Hospitality announced its expansion to the Mediterranean with its newest location in Evia, Greece, a stunning island known for its natural beauty and rich cultural heritage. Selina Kaminos Evia is more than just a seaside hotel; it's a wellness retreat offering an escape from the noise, stress, and daily routine. The unique blend of Selina's laid-back atmosphere, locally-inspired design, and innovative wellness programs will perfectly complement the island's serene surroundings. Guests can immerse themselves in Evia's picturesque landscapes and rich culture while enjoying a truly authentic experience.
|
JUPW | Hot Stocks08:57 EDT Jupiter Wellness signs consulting agreement with David Gold, D3M - Jupiter Wellness signed a consulting agreement with David Gold and his firm D3M Licensing Group. D3M will bring the power of its brand ambassador network and channel partnerships to support the highly anticipated global launch of Safety Shot, the world's first rapid blood alcohol detoxification product.
|
X CLF | Hot Stocks08:57 EDT U.S. Steel rejects Cleveland-Cliffs $7.3B offer to acquire the company - Last night, U.S. Steel (X) confirmed that it has invited Cleveland-Cliffs (CLF) announced strategic review process. The company previously disclosed it has commenced a formal review process, with the assistance of outside financial and legal advisors, to evaluate strategic alternatives for the company after receiving multiple unsolicited proposals that ranged from the acquisition of certain production assets to consideration for the whole company. The company had received an unsolicited cash and stock proposal from Cleveland-Cliffs to acquire all of U. S. Steel's outstanding shares. The letter said, "I am writing on behalf of United States Steel Corporation (the "Company") in response to Cleveland-Cliffs Inc.'s proposal letter dated July 28, 2023 and further updated on August 11, 2023. Since receiving your initial proposal, the Company's Board has met multiple times, with the assistance of our financial advisors, Barclays and Goldman Sachs, and our legal advisors, Milbank and Wachtell, to evaluate the merits and risks of your proposal. At my and the Board's direction, our advisors indicated our willingness to enter into an NDA with you on August 7, 2023, so that we could have further clarity on several key issues, including valuation of the stock component of your proposal, regulatory risk and timing as well as the prospects for the combined company. We discussed with your counsel questions that would need to be better understood in order for both of us to appropriately assess the antitrust risk of your proposal; and while your counsel agreed that this would need to be analyzed, and was amenable to our proposal to work on this together, this still has not happened. After multiple conversations about, and our team's engagement in good faith negotiations over, the terms of the NDA, we were shocked to receive a letter on Friday, August 11th stating that you refused to sign the nearly completed NDA unless we agree to the economic terms of your proposal in advance. As you well know, our Board - or any board - could not, consistent with its fiduciary duties, agree to a proposal of which 50% is represented by your stock without conducting a thorough and completely customary due diligence process, to evaluate the risks and potential upsides and downsides inherent in the transaction, including the stock component. Doing otherwise would be tantamount to accepting a price without knowing what it in fact represents. Nor could our Board agree to your "headline price" without appropriate discussion - under NDA - regarding the contribution of U. S. Steel to the value of the combined businesses. Pushing our Board to do so is in essence a demand that it breach its fiduciary duties. The Company, led by the Board and management team, has made significant progress transforming the Company into a customer-centric, world-competitive Best for All(R) steelmaker as we continue to win in strategic markets, move down the cost curve and move up the talent curve. This proven strategy has provided customers with profitable steel solutions for people and the planet, while rewarding our stockholders. At this juncture, we cannot determine whether your unsolicited proposal properly reflects the full and fair value of the Company. For all of the above reasons, the Board has no choice but to reject your unreasonable proposal. The U. S. Steel Board remains committed to maximizing value for stockholders, and to that end has decided to initiate a formal review process to evaluate strategic alternatives. If you would like to engage in that process, we invite you to reach out to our financial and legal representatives and welcome you to join our process."
|
NWTN | Hot Stocks08:56 EDT NWTN Inc. to acquire strategic stake in Evergrande New Energy auto - NWTN Inc. has reached an agreement to make a strategic investment of $500M in China Evergrande New Energy, a Chinese automobile manufacturer that specializes in developing electric vehicles. On August 14, NWTN and EVGRF entered into a share subscription agreement pursuant to which NWTN will acquire approximately 27.50% of the total number of enlarged issued ordinary shares of EVGRF upon closing and the right to nominate a majority of EVGRF's board. The proposed transaction is expected to close in Q4, subject to conditions including but not limited to the effectiveness of the debt restructuring of the Evergrande Group, confirmation of a debt repayment plan by certain creditor of EVGRF, and receipt of applicable regulatory and shareholder approvals. Based in Dubai, UAE, NWTN has a full vehicle assembly facility in Abu Dhabi.
|
IMNN | Hot Stocks08:56 EDT Imunon appoints Sachet Shukla to board of directors - IMUNON announces the addition of Sachet A. Shukla, Ph.D. to the company's scientific advisory board. Dr. Shukla is Assistant Professor, Department of Hematopoietic Biology and Malignancy, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. He joins current advisory board members Dan H. Barouch, M.D., Ph.D., John W. Shiver, Ph.D., and Luke D. Handke, Ph.D.
|
DCT | Hot Stocks08:55 EDT Duck Creek announces partnership with Artigem - Duck Creek Technologies announces its partnership with technology-enabled contents and jewelry service provider Artigem. Through this collaboration, Duck Creek customers will gain access to Artigem's innovative SpeedCheck software, enabling them to update the value of scheduled jewelry items conveniently and accurately in real time. "Artigem's SpeedCheck software ensures an insurer's existing book of scheduled jewelry gets and stays at an accurate insured to value," said Artigem's CEO, Kurt Artinger. "We don't value the house on year one and then let it sit on the books for 20 years. So why is this an acceptable business practice for jewelry, which experiences greater price fluctuation than home values? SpeedCheck software allows underwriting and agents to confidently price jewelry without a current appraisal and maintains the pricing for the item's life."
|
CMND CTS | Hot Stocks08:54 EDT Clearmind Medicine announces collaboration with CTS - Clearmind Medicine (CMND) announced that the Company and CTS (CTS) have agreed to collaborate on product development. As part of the collaboration, Clearmind Medicine will have access to the CTS' state-of-the-art facilities, allowing it to expand its research and development capabilities. Furthermore, the collaboration provides Clearmind access to CTS' global networks and industry connections, the ability to leverage CTS' expertise in manufacturing and marketing, as well as benefit from CTS' vast industry experience and guidance, ensuring that the Company's treatments meet the highest standards of quality, safety, and efficacy. "We are honored to collaborate with such a prominent pharmaceutical company. CTS' support and expertise will be invaluable as we advance our research and development efforts in psychedelic-based therapeutics. This significant milestone recognizes Clearmind Medicine's innovative approach as well as highlights the growing interest in the field of psychedelic-based therapies within the pharmaceutical industry. Together, we have the opportunity to revolutionize mental health treatments and provide much-needed relief to individuals suffering from a range of mental health conditions," said Clearmind's Chief Executive Officer, Dr. Adi Zuloff-Shani.
|
TMC | Hot Stocks08:54 EDT Metals Company announces $27M registered direct offering - TMC the metals company has entered into a securities purchase agreement with certain investors for the purchase of 13,461,540 common shares of the Company. without par value, and accompanying Class A warrants to purchase up to 6,730,770 Common Shares in a registered direct offering. Each Common Share and the accompanying Class A Warrant to purchase 0.5 Common Shares are being sold at a price of US$2.00. The Class A Warrants have an initial exercise price of US$3.00 per share, subject to certain adjustments therein, are exercisable immediately upon issuance and will expire on December 31, 2027. Gross proceeds to the Company from the offering are expected to be approximately US$27 million, before deducting the financial advisors' fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering on working capital and general corporate purposes. In addition, certain investors may purchase up to an aggregate of 5,500,000 additional Shares and accompanying Class A Warrants to purchase up to an aggregate of 2,750,000 additional Common Shares upon notice to the Company on or before September 15, 2023 if the closing price of the Common Shares on the trading day before such investor's notice is $3.00 or less for an aggregate of up to an additional $11 million. ERAS Capital LLC, the family fund of the Company's director, Andrei Karkar, and existing shareholder, agreed to purchase 5,000,000 Common Shares and accompanying Class A Warrants to purchase 2,500,000 Common Shares for a total purchase price of US$10 million. In addition, Allseas Group S.A., a strategic partner of the Company and existing shareholder, agreed to purchase 3,500,000 Common Shares and accompanying Class A Warrants to purchase 1,750,000 Common Shares for a total purchase price of US$7 million. The Company's Chief Executive Officer and Chairman, Gerard Barron, the Company's Chief Financial Officer, Craig Shesky, and other members of the Company's board of directors also agreed to purchase Securities in the offering. The initial closing of the offering is expected on or about August 16, 2023, subject to the satisfaction of customary closing conditions. Two additional closings for US$2.5 million and US$6.5 million are expected to occur on or before November 30, 2023 and January 31, 2024, respectively, with respect to one of the investors in the offering pursuant to the terms of the securities purchase agreement. Cantor Fitzgerald & Co., Wedbush Securities LLC, EAS Advisors LLC, Fearnley Securities Inc. and ThinkEquity LLC are engaged by the Company as financial advisors.
|
ITRG | Hot Stocks08:53 EDT Integra files independent PEA report for Wildcat, Mountain View projects - Integra Resources announces the filing of an independent Preliminary Economic Assessment, PEA, technical report for the Wildcat Project and Mountain View Project located in western Nevada. The PEA demonstrates the potential for a low-cost, high-margin, heap leach gold-silver operation with a phased development and production strategy and robust economics. The average annual production of Wildcat & Mountain View and the DeLamar Project on a combined basis is expected to exceed 200kozs of gold equivalent, demonstrating one of the largest heap leach production profiles among precious metal developers in the Great Basin. Integra's President, CEO & Director, Jason Kosec commented: "The successful Wildcat & Mountain View PEA demonstrates two high-margin, low-cost, heap leachable gold and silver deposits with a strong combined production profile, low pre-production capex and robust economics. When combined with the DeLamar Project, Integra demonstrates the path to becoming +200koz AuEq per annum producer in the prolific Great Basin. For the remainder of the year, the team is focused on delivering two more significant milestones at DeLamar, including the updated mineral resource estimate in Q3 and the submission of the Mine Plan of Operations in Q4."
|
EUMNF | Hot Stocks08:52 EDT Euro Manganese reports cash, equivalents of C$10.9M at end of Q3 - The reduction in cash position is mainly attributable to: expenses related to project advancement, including award of the EPCM contract; commissioning of the Demonstration Plant; certain land rental payments; amendments to the ESIA; and administrative expenses related to project financing efforts and the corporate office. Additional expenses were incurred for site due diligence and completion of the Becancour Plant Scoping Study evaluating the construction and operation of a Dissolution Plant at the Port of Becancour in Quebec. Sufficient funding for delivery of near-term project milestones including advancing permitting for the Chvaletice Project, completing commissioning of the Demonstration Plant and its initial operation, and for general & administration expenses for the next 12 months. Additional funding will be required for execution of the EPCM services for the Project, certain scheduled payments for land acquisitions, future operation of the Demonstration Plant, as well as construction of future infrastructure and facilities for the Chvaletice Project and to advance the Company's North American strategy, including the Becancour Plant Feasibility Study. Dr. Matthew James, President & CEO of Euro Manganese, commented: "We continued to advance the Chvaletice Manganese Project during the third fiscal quarter and to date. Production of on-spec high-purity manganese metal from the Chvaletice Demonstration plant was a significant milestone. Additionally, the appointment of Wood as our EPCM partner signals our commitment to building a world-class facility in the Czech Republic to produce high-purity manganese, an essential component in lithium-ion batteries for electric vehicles. We remain focused on producing on-spec high-purity manganese sulphate from our onsite Demonstration Plant, which would further de-risk our process flowsheet and demonstrate our capacity to produce battery-grade manganese products at scale. Developments at our Becancour Project subsequent to the quarter make this opportunity increasingly attractive for the Company and its stakeholders. The positive Scoping Study delivered strong preliminary project economics for modest initial capital and estimated a short, 2-year build time. We now intend to proceed with a Feasibility Study to further refine Plant design, costs, and economics. Our MoU with MMC provides us with feedstock flexibility and enables us to potentially operate Becancour as a stand-alone project. More importantly, it outlines a path to bring Company production and cash-flow forward by at least a year, in advance of our Chvaletice Manganese Project in the Czech Republic. I am very excited about the potential significant value that Becancour could deliver for our stakeholders."
|
MIK | Hot Stocks08:51 EDT Michaels unveils new brand identity - Michaels unveiled a new brand identity focused on helping core and new customers alike bring their creative ideas to life. An updated tagline of "Everything to Create Anything" supports the new brand strategy by expanding to reach the many kinds of creativity represented in Michaels' assortment. "Our customers' creativity is the driving force of the Michaels brand, and it's an honor to play a special role in helping them bring their ideas and projects to life," said Mandy Rassi, Senior Vice President and Chief Marketing Officer at Michaels. "With a new brand strategy and purpose focused on fueling the joy of creativity, Michaels is well-positioned to meet creatives where they are while supporting every step of their journey and continuing to grow as a leader in our category."
|
PBLA | Hot Stocks08:50 EDT Panbela announces issuance of new patent in Europe for production of SBP-101 - Panbela Therapeutics announced an Issue Notification for the European patent 2019213664 titled "METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL". This patent, developed in collaboration with Syngene International Ltd., an integrated research, development, and manufacturing services company, claims a novel process with a reduced number of synthetic steps from seventeen to six to produce SBP-101. The patent is valid until 2039 and is undergoing individual country validations. Jennifer Simpson, PhD, MSN, CRNP, President & Chief Executive Officer of Panbela Therapeutics, commented, "We're excited to have this patent issued in Europe and look forward to individual country validations. With the addition of Europe to the previous issuance in the US and Australia, this further expands our patent portfolio and supports our global clinical programs." First issued in the United States in 2021 and now in several other territories, this patent covers a shorter synthesis of SBP-101. Which provides many benefits including a scalable, efficient and cost-effective manufacturing process to enable future commercialization. Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International Ltd., said, "We have been partnering with Panbela for the last decade and we are proud of the successful collaboration. Syngene's dedication to optimizing efficiency and accelerating medicine delivery is evident in the development of the novel process, which reduces the synthetic steps from seventeen to six. Reducing the number of steps in production and simplifying the manufacturing process means that the drug will reach patients faster. The patent issued in multiple markets and now in Europe is a testament to our combined expertise and commitment to improving patient outcomes."
|
ENGIY MSFT | Hot Stocks08:50 EDT Engie, Microsoft collaborate on community solar projects - ENGIE North America is collaborating with Microsoft on the development of two community solar projects in Illinois that will serve historically excluded communities and significantly reduce electricity costs for them. ENGIE will develop, construct, and operate two new community solar gardens, one in Lena, IL west of Rockford, and a second in downstate Illinois. Together, the projects are expected to have a capacity of 4.75 MW, enough to meet the annual electricity needs of more than 1,000 average Illinois households with clean, carbon emissions-free power. ENGIE and Microsoft will work with leading community solar provider, Solstice, who engages directly with residents, businesses, and community organizations to enroll and manage community solar customers with local community gardens like the ones in Lena and downstate Illinois. Community solar enables households, small businesses and other organizations to benefit from renewable electricity without the need to install their own panels by effectively sharing local, centralized installations. Solstice's partnership and community organizing model help provide access to renewables for the estimated 77% of Americans who do not have access to roof space or the financial means to install rooftop systems and expands access to traditionally excluded populations.
|
EUDA | Hot Stocks08:49 EDT EUDA Health receives Nasdaq notification on minimum bid price requirement - EUDA Health received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. The Notice does not result in the immediate delisting of the Company's securities from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share and, based upon the closing bid price of the Company's securities for the 30 consecutive business days for the period ending August 9, 2023, the Company no longer meets this requirement.
|
CPRX ESAIY | Hot Stocks08:48 EDT Catalyst Pharmaceuticals announces multiple abstracts on FYCOMPA - Catalyst Pharmaceuticals (CPRX) announced that multiple abstracts highlighting FYCOMPA CIII will be presented at the upcoming 35th International Epilepsy Congress, IEC, taking place on September 2 - 6, 2023 in Dublin, Ireland. These are presentations by Eisai (ESAIY), which holds the rights to FYCOMPA in countries and regions outside the U.S. Some abstracts will also be considered for publication in Epilepsia following the IEC. "These findings, which are being presented at IEC, further validate and add to the growing body of evidence supporting the benefits of perampanel in the treatment of seizure disorders," said Gary Ingenito, MD, PhD, Chief Medical and Regulatory Officer of Catalyst. "We are pleased this investigative work will be presented at such a prestigious forum."
|
LGVN | Hot Stocks08:48 EDT Longeveron files amended registration statement for rights offering - Longeveron filed an amended registration statement with the Securities and Exchange Commission to conduct a tradable subscription rights offering to holders of its Class A common stock, Class B common stock and warrants to purchase its Class A common stock. The rights offering is being made through a distribution of five tradable subscription rights to purchase shares of Class A common stock, for each share of common stock and warrant to purchase common stock owned on the record date, at a $3.00 subscription price per share. The distribution of the subscription rights must be settled within two business days of the transaction date. So, to be considered a stockholder of record, you must own the stock in your brokerage account as of 5:00 PM Eastern Time on Wednesday, August 16, 2023, which is two trading days before the record date of Friday, August 18, 2023. The rights offering also includes an over-subscription privilege, entitling each rights holder that exercises all of its basic subscription rights in full the ability to purchase additional shares of Class A common stock that remain unsubscribed at the expiration of the rights offering, subject to the availability and pro rata allocation of shares among those exercising this over-subscription privilege. The amended registration statement also covers the placement of unsubscribed shares of Class A common stock for an additional period of up to 45 days following expiration of the offering, as well as the potential resale by the Company's principal stockholders, directors and executive officers of subscription rights during the period for which the subscription rights may be transferred in accordance with the terms of the rights offering.
|
XMTR | Hot Stocks08:47 EDT Xometry adds new dashboard collaboration tool to its ai-powered marketplace - Xometry unveiled a new cloud-based collaboration tool that lets employees at the same company manage projects within Xometry's AI-powered platform. The new dashboard provides engineering, procurement and supply chain colleagues with visibility into existing projects. An important addition to Xometry's online marketplace, the dashboard helps streamline order management, increase efficiency and drive data-based decision-making. "Our new dashboard further accelerates Xometry's continued adoption into the enterprise and supports a growing number of clients who rely on us to strengthen their supply chains and provide additional capacity for large-volume production runs," said Randy Altschuler, Xometry CEO. "With it, our customers can manage the production of individual parts to entire supply chain projects, empowered by data and insights that help them drive real-time decision-making."
|
INNV | Hot Stocks08:46 EDT InnovAge appoints Sparks to its board of directors - InnovAge announced the appointment of Teresa Sparks to its Board of Directors, effective immediately. Sparks joins InnovAge's Board as Sean Traynor of Welsh, Carson, Anderson & Stowe steps down. She previously served as the Executive Vice President and Chief Financial Officer for Envision.
|
FRSX | Hot Stocks08:45 EDT Foresight Autonomous signs agreement with global vehicle manufacturer - Foresight Autonomous announced the signing of an agreement for two proof of concept, POC, projects with a leading global vehicle manufacturer. The purpose of these POC projects is to assess the accuracy of Foresight's unique automatic calibration capabilities in enhancing 3D depth perception. In addition, the vehicle manufacturer will assess Foresight's Mono2Stereo perception enhancement solution to be used with its existing mono cameras which have different fields of view. Upon successful completion of the projects, the vehicle manufacturer may integrate Foresight's technology into its passenger vehicles. "We believe that our collaboration with another leading global vehicle manufacturer validates the importance of Foresight's technology in the automotive world and could lead to additional opportunities in the automotive sector. This vote of confidence from an important player in the automotive industry reinforces our commitment to develop advanced software-based vision solutions that will be widely implemented and could save lives by redefining road safety," said Haim Siboni, CEO of Foresight.
|
INFN | Hot Stocks08:45 EDT Infinera, LightRiver to showcase power of coherent pluggables - Infinera and LightRiver announced the successful completion of a multi-vendor interoperability technology demonstration that leverages the latest generation of coherent pluggable solutions and validates how network orchestration can provide substantial improvements in network efficiency and enable new high-speed business services. The demonstration is based on Infinera's ICE-X intelligent coherent pluggable technology and LightRiver's netFLEX Transport Domain Orchestration and Control Software combined with Infinera's Intelligent Pluggables Manager software, providing seamless multi-vendor network automation. The innovative multi-vendor demonstration illustrates how LightRiver's netFLEX along with Infinera's IPM can enable seamless network operation of multi-vendor networks leveraging the efficiencies of intelligent coherent pluggable solutions in conjunction with the latest generation of routers and FTTX PON solutions. The demonstration includes Infinera's ICE-X line of intelligent coherent pluggables deployed in third-party host devices, including routers from Juniper Networks operating over a Smartoptics open ROADM system and the leading FTTX PON solution. The demonstration validates how network operators can leverage next-generation coherent pluggables to provide significant improvement in network efficiencies and expand network capacity by as much as 40 times, while also delivering new high-speed business services to currently underserved remote rural areas, including over single-fiber FTTX PON infrastructures.
|
TMC | Hot Stocks08:44 EDT Metals Company expects cash to fund operations at least 12 months from today - The company said, "At June 30, 2023, TMC held cash of $20.0 million and held no debt. We believe that our cash on hand, the expected net proceeds from the registered direct offering and borrowing availability under our recently amended and extended credit facility with an affiliate of Allseas will be sufficient to meet our working capital and capital expenditure commitments for at least the next twelve months from today."
|
BOWN | Hot Stocks08:42 EDT Bowen Acquisition announces separate trading of ordinary shares, rights - Bowen Acquisition announced that, commencing on or about August 17, 2023, holders of its units sold in the Company's initial public offering may elect to separately trade the Company's ordinary shares and rights included in the units. The ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols "BOWN" and "BOWNR," respectively. No fractional rights will be issued upon separation of the units and only whole rights will trade. Those units not separated will continue to trade on Nasdaq under the symbol "BOWNU." Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into ordinary shares and rights. Bowen Acquisition Corp is a Cayman Islands corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region although the Company intends to initially focus on target businesses in the infrastructure, engineering and construction, industrial and renewables industries. The Company's management team is comprised of Jiangang Luo, Chief Executive Officer, Jing Lu, Chief Financial Officer, Na Gai, Chairwoman of the Board of Directors and Lawrence Leighton, Wei Li and Jun Zhang, each a Director of the Company.
|
LTRN | Hot Stocks08:42 EDT Lantern Pharma receives notice of allowance from USPTO for ATRT treatment - Lantern Pharma received a notice of allowance from the United States Patent and Trademark Office, or USPTO, covering a method of treatment for Atypical Teratoid Rhabdoid Tumor, or ATRT, using LP-184, an aggressive and rapidly growing form of cancer of the central nervous system, or CNS.
|
CGRN | Hot Stocks08:42 EDT Capstone says CEO Darren Jamison resigns, effective August 22 - Capstone Green Energy announced that Darren Jamison has resigned as President and CEO, and board member of Capstone Green Energy, effective August 22 The board will be initiating a search process to identify a permanent President and CEO. Robert C. Flexon, Capstone Board Chair, was appointed as Executive Chairman of the board effective August 9, and was also appointed to serve as Interim President and CEO, from the effective date of Mr. Jamison's resignation until a successor is named. In connection with Mr. Flexon's transition to Executive Chairman, Denise M. Wilson was appointed Lead Independent Director of the board. John J. Juric, who joined Capstone as Chief Financial Officer in March 2023, will continue to provide financial leadership for the company.
|
LQDT | Hot Stocks08:42 EDT GovDeals completes $4B in cumulative auction sales - GovDeals announced it has completed $4 Billion in cumulative auction sales. This remarkable achievement underscores the company's unwavering commitment to sustainable business practices and transparent surplus sales. Since its inception, just over two decades ago, GovDeals has built a transparent, highly effective marketplace that connects buyers and sellers of surplus assets across North America, amassing a client base of over 17,000 sellers and more than one million registered buyers, with access to more than five million qualified buyers across all Liquidity Services Marketplaces. High engagement by both buyers and sellers across the US and Canada has been a catalyst for its consistent, long-term growth. GovDeals achieved the milestone of $1 Billion in total sales in March 2015, surpassing $2 Billion by March 2019, and crossing the impressive threshold of $3.5 Billion in sales by September 2022. These achievements were driven by the successful sale of virtually every asset type in the public sector infrastructure, including automobiles, trucks, buses, railway cars, aircraft, construction and heavy equipment assets, IT equipment, and real estate.
|
AMOT | Hot Stocks08:41 EDT Allied Motion to change name, symbol - Allied Motion announced that shareholders approved its corporate name change to Allient Inc. at a special meeting of shareholders held on August 11. The new name will be effective August 23 and at the opening of the markets that day, the company's shares will commence trading under the new ticker (ALNT) on the Nasdaq.
|
MYMD | Hot Stocks08:39 EDT FDA accepts MyMD Pharma's IND for study of TNF-a inhibitor MYMD-1 in RA - MyMD Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug Application IND to evaluate the safety, efficacy, pharmacodynamics and pharmacokinetics of oral TNF-a inhibitor MYMD-1 in patients with active rheumatoid arthritis RA. The application was based on preclinical data showing that MYMD-1 significantly reduced swelling and other clinical arthritis measures compared to widely used RA therapy, Enbrel or etanercept.1 The Company plans to initiate discussions with CRO vendor IQVIA on timing of a Phase 2 study in this indication. MYMD-1 is an oral, next-generation TNF-a inhibitor with the potential to transform the way TNF-a based diseases are treated due to its selectivity and ability to cross the blood brain barrier. Its ease of oral dosing is a significant differentiator compared to currently available TNF-a inhibitors, all of which require delivery by injection or infusion. MYMD-1 has also been shown to selectively block TNF-a action where it is overactivated without preventing it from doing its normal job of responding to routine infection. MYMD-1 is doubly effective at inhibiting inflammation by blocking both TNF-a and IL-6 activity, whereas currently approved anti-TNF and anti-IL-6 treatments for RA can only target one or the other. In addition, in early clinical studies it has not been associated with serious side effects known to occur with traditional immunosuppressive therapies that treat inflammation. "FDA acceptance of an IND in RA for our next-generation oral TNF-a inhibitor, MYMD-1, is our most significant milestone as it adds substantial momentum to our clinical program with sufficient funding and targets one of the largest potential market opportunities," said Chris Chapman, M.D., president, director, and chief medical officer of MyMD. "We are excited to initiate discussions with our CRO regarding a Phase 2 clinical trial in RA and believe the statistically significant biomarker data from the Phase 2 study in sarcopenia show MYMD-1 has the potential to disrupt the TNF-a inhibitor market and offer therapeutic benefit to patients with a range of chronic inflammatory conditions."
|
JYNT | Hot Stocks08:38 EDT Joint Corp. names Lori Abou Habib as new Chief Marketing Officer - The Joint Corp. announces the hiring of Lori Abou Habib, as its new Chief Marketing Officer. Reporting directly to Peter Holt, President and CEO of The Joint Corp., Abou Habib is tasked with leading marketing and strategic planning to advance enterprise initiatives and grow performance of clinics, franchise prospects and consumer awareness. Prior to The Joint, Abou Habib served for six years as senior vice president and chief marketing officer of Sonic.
|
ISPR | Hot Stocks08:38 EDT Ispire Technology announces key leadership appointments - Ispire Technology has appointed Michael Wang as its Co-CEO. Wang previously served as CFO. Concurrently, Daniel Machock was appointed as the new CFO. Wang has assumed the role of Co-CEO alongside Tuanfang Liu, as Co-CEO. Machock has experience from his tenures at Appetize Technologies, Chrome River Technologies, and other firms.
|
AEE | Hot Stocks08:34 EDT Ameren Executive Chairman Warner Baxter to retire, Marty Lyons to succeed - Ameren announced that Warner Baxter, executive chairman of the board of directors, will retire from Ameren and its board of directors, effective Nov. 2, after a 28-year career with the company. Marty Lyons, president and CEO, has been elected by the board of directors to the additional role of chairman of the board, also effective Nov. 2.
|
CARV | Hot Stocks08:32 EDT Carver Bancorp names Craig MacKay as interim CEO - Carver Bancorp announced that its board of directors unanimously appointed Craig MacKay as interim President & CEO, effective October 1. His appointment will facilitate a smooth leadership transition until a permanent President & CEO is named after a national search is conducted. Carver previously announced that its current President & CEO, Michael Pugh, will depart on September 30 to become the CEO of the Local Initiatives Support Coalition, a national nonprofit organization.
|
BNGO | Hot Stocks08:29 EDT Bionano Genomics announces CFO transition, appointment of Kama as CFO - Bionano Genomics announced that Gulsen Kama will serve as its next Chief Financial Officer, CFO, effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory role. Kama was most recently Chief Financial Officer at Northern Data AG.
|
ICAD... | Hot Stocks08:28 EDT Google Health expand integration of its AI in iCAD's ProFound Breath Suite - iCAD (ICAD) announced it signed an amendment to its development and commercialization agreement with Google Health (GOOG;GOOGL), which will enable iCAD to integrate Google's AI technology with its ProFound Breast Health Suite for 2D Mammography for use worldwide upon regulatory approval as an independent reader for breast cancer screening for 20 years. "The conventional double-reading workflow utilized by most countries, where mammograms are assessed by two separate radiologists, has become increasingly challenging due to the scarcity of radiologists worldwide. As the global radiologist shortage continues to impact patient care, healthcare organizations are seeking clinically-proven solutions to help their radiology departments run more efficiently and adeptly handle the workload in front of them. By leveraging the remarkable capabilities of ProFound Detection, iCAD seeks to provide a viable alternative to the current double-reading workflow," said Dana Brown, President and CEO of iCAD.
|
VSAT | Hot Stocks08:27 EDT ViaSat Real-Time Earth opens ground station in Japan - Viasat opened a Real-Time Earth - RTE - ground station in Hokkaido, Japan, now enabling RTE customers the ability to downlink Ka-band payload data in the northwestern Pacific at the site hosted by RTE partner Infostellar. This new ground site gives RTE customers access to a strategic location that reduces the time it takes to deliver mission critical data. For Viasat, the Hokkaido ground station is a vital link in supporting high data rate remote sensing missions in polar and inclined orbits through the RTE network of Ka-band antenna systems.RTE plans to expand the Ka-band capability with sites in Alaska and Argentina later this year. RTE offers global S/X-band services at all sites.
|
ABSI | Hot Stocks08:26 EDT Absci appoints Jonasson as CFO, CBO - Absci announced today that Zach Jonasson, Ph.D., has been appointed Chief Financial Officer, CFO, and Chief Business Officer, CBO. In this dual role, Dr. Jonasson will join Absci's executive leadership team and replace CFO Greg Schiffman, who will retire after a successful tenure with the company and a distinguished career in the biotech industry. Dr. Jonasson is the co-founder and Managing General Partner of Phoenix Venture Partners (PVP) and Convergent Ventures, both venture capital firms.
|
ABSI | Hot Stocks08:25 EDT Absci expects cash to fund operations into late 2025 - Absci continues to anticipate at least ten new Active Programs in 2023, based on the company's current partnership pipeline. Absci also expects to generate more cash from execution on partnered programs this year and going forward, as compared to prior years, given the shift from cell line development to discovery programs. Absci continues to expect a gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receipts, of approximately $90 million, below prior year use of $105 million. Absci also continues to focus its investments and operations on strategic initiatives and near-term inflection points, providing cash and cash equivalents and short-term investments into late 2025, consistent with previous disclosures.
|
XELA | Hot Stocks08:21 EDT Exela Technologies receives notice of non-compliance from Nasdaq - On August 11, 2023, Exela received a notice of non-compliance from Nasdaq Stock Market notifying the Company that, as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission. Under Nasdaq's listing rules, the Company has 60 calendar days to submit a plan to regain compliance. If the plan is accepted by Nasdaq, the Company can be granted up to 180 calendar days from the Form 10-Q due date, or until or until February 5, 2024, to regain compliance. The Company expects to complete its Form 10-Q and intends to file the Form 10-Q as soon as practicable to regain compliance with the Rule within the time period to provide the plan of compliance.
|
VIRX | Hot Stocks08:13 EDT Viracta Therapeutics expects cash to fund operations into late 2024 - Cash position - Cash, cash equivalents, and short-term investments totaled approximately $72.9 million as of June 30, 2023, which Viracta expects will be sufficient to fund its operations into late 2024 excluding any additional borrowing under a $50.0 million credit facility, of which $25.0 million remains available, at the Company's request and subject to the discretion of the lenders
|
VYNE | Hot Stocks08:09 EDT VYNE Therapeutics expects cash to fund operations through 2023 - As of June 30, 2023, VYNE had cash and cash equivalents and restricted cash of $20.7 million. VYNE currently anticipates that its cash and cash equivalents and restricted cash as of June 30, 2023 will be sufficient to fund its operations through the end of 2023, without giving effect to any potential business development transactions or financing activities, including any sales under its equity line of credit with Lincoln Park or the Company's at-the-market offering program.
|
LDOS | Hot Stocks08:09 EDT Leidos awarded new task order to support centers for Medicare, Medicaid services - Leidos has been awarded a new task order by the Centers for Medicare and Medicaid Services. The hybrid firm-fixed-price, time and materials order has a total estimated value of $197M. Leidos will support the Office of Information Technology and the Infrastructure and User Support Group through this order. Through this order, Leidos will deliver a personalized and modern IT support service to CMS. This encompasses the implementation of new processes to streamline end-users' experiences and the integration of advanced technologies across multiple platforms while maintaining the highest standards of data protection for CMS.
|
FFIE | Hot Stocks08:07 EDT Faraday Future makes first delivery of Ultimate AI Techluxury FF 91 2.0 Futurist - The company states: "Faraday Future Intelligent Electric announced the official delivery of its first Ultimate AI Techluxury FF 91 2.0 Futurist Alliance. This marks FF's entry into its revenue generation stage and the formation of a complete operational closed loop. A delivery ceremony was held for FF's first spire user on August 12. The first group of distinguished users and Developer Co-Creators, as previously announced by FF, consists of Rem D Koolhaas, a well-known design industry veteran, Jason Oppenheim, a renowned real estate agent specializing in luxury properties in Los Angeles, California, and a user who comes from "Private Collection Motors", a luxury car dealership based in Costa Mesa, California. PCM, a major player in the luxury car market here in SoCal, is the Company's first user to receive its FF 91 2.0 Futurist Alliance. The Company believes this is indicative of how the US luxury car industry values FF's "Ultimate AI TechLuxury" product and brand. PCM is also invited to be part of the FF Developer Co-Creation Mission and take on the role of a FF Developer Co-Creation Officer. With its industry expertise, it will be offering co-creation services. The Company believes this will add value and benefits in return. This move perfectly embodies FF's core philosophy and business model of value co-creation and value co-sharing."
|
CLNN | Hot Stocks08:07 EDT Clene expects cash to fund operations into mid-2024 - Clene's cash, cash equivalents and marketable securities totaled $49.2 million as of June 30, 2023, compared to $23.3 million as of December 31, 2022. Clene expects that its resources as of June 30, 2023, will be sufficient to fund its operations through mid-2024.
|
GEHC | Hot Stocks08:06 EDT GE HealthCare gets FDA okay for wireless monitoring solution Portrait Mobile - GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration FDA for its Portrait Mobile wireless and wearable monitoring solution. The Portrait Mobile platform enables real-time continuous monitoring with a personalized view of the patient's vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit.
|
GOEV | Hot Stocks08:06 EDT Canoo finalizes incentive package with Oklahoma, Cherokee Nation - Canoo has finalized today agreements on workforce and economic development incentives from the state of Oklahoma and the Cherokee Nation for its vehicle assembly and battery module manufacturing plants in Oklahoma City and Pryor, respectively. The estimated combined value of the incentive agreements is up to $113M over 10 years. The agreements require the company to meet job creation and investment targets. The agreement with the Oklahoma Department of Commerce will enable Canoo to receive performance-based payments from the Quality Jobs program and the Quick Action Closing Fund and to receive workforce training support. The Department of Commerce has issued a letter confirming Canoo's eligibility for certain state tax credit and tax exemption programs. Canoo also signed on-the-job training agreements with the Cherokee Nation. Under these agreements, the Cherokee Nation is committed to working with Canoo to identify skilled workers within their reservation to staff the battery module manufacturing facility in Pryor. Canoo will invest more than $320M in its Oklahoma City assembly facility and Pryor battery module manufacturing plant. Together, these facilities will create more than 1,360 jobs at wages that exceed average state and local salaries, according to Department of Commerce data.
|
ELOX | Hot Stocks08:06 EDT Eloxx Pharmaceuticals reports drug response in all patients treated with ELX-02 - Eloxx Pharmaceuticals reported additional positive results from its proof-of-concept Phase 2 open-label clinical trial of ELX-02 for the treatment of Alport syndrome after eight weeks of treatment. Electron microscopy assessment of kidney biopsies demonstrated an improvement in foot process effacement in all three treated patients. These results are consistent with the disease modifying effect of restoration of COL4A4 protein with ELX-02 and with previously reported data from preclinical studies. "These are profound results. The improvement in podocyte foot process effacement in all three patients treated confirms the disease modifying potential of ELX-02. Combined with the reduction of proteinuria achieved in one patient, these data strengthen our confidence in ELX-02's potential to treat Alport syndrome patients with nonsense mutations," said Sumit Aggarwal, President and Chief Executive Officer of Eloxx. "We look forward to initiating a pivotal trial as we believe ELX-02 has the potential to be transformational in this underserved patient population."
|
CHPT | Hot Stocks08:04 EDT ChargePoint appoints Sherice Torres as Chief Marketing Officer - -ChargePoint announced the appointment of Sherice Torres as Chief Marketing Officer. Torres joins ChargePoint's executive team to lead global marketing as the EV ecosystem enters a period of exponential growth. "I look forward to leading the marketing organization through the company's next phase of growth, and applying myself as well as my experience to a more sustainable future of transportation."
|
NRBO | Hot Stocks08:03 EDT NeuroBo Pharmaceuticals names Hyung Heon Kim as CEO - NeuroBo Pharmaceuticals announced the appointment of current Board member, Hyung Heon Kim, as the company's CEO and President, effective immediately. Kim succeeds Joseph Hooker, who served as interim CEO and President since January 2023. Prior to his appointment as CEO and President, Kim served as the General Counsel and a Senior Vice President of Dong-A ST Co, Ltd.
|
CNSP | Hot Stocks07:59 EDT CNS Pharmaceuticals expects cash to fund operations into 4Q23 - s of June 30, 2023, the Company had cash of approximately $4.3 million and working capital of approximately $2.1 million. The Company's current expectation is that the cash on hand is sufficient to fund operations into the fourth quarter of 2023, through the topline data readout for the Berubicin potentially pivotal study. The timing and costs of clinical trials are difficult to predict and trial plans and timing of milestones may change in response to evolving circumstances and as such the foregoing estimates may prove to be inaccurate.
|
NLST SSNLF | Hot Stocks07:57 EDT Netlist announces final judgment in case against Samsung - Netlist (NLST) announced the entry of a Final Judgment in the case of Netlist v. Samsung Electronics (SSNLF) in the United States District Court for the Eastern District of Texas. The Court's Final Judgment upheld the jury's verdict in the April 2023 trial and confirmed that Samsung willfully infringed Netlist's patented technologies. Chief Judge Gilstrap ordered Netlist receive $303,150,000 as a reasonable royalty for Samsung's infringement of Netlist's patents for a limited past damages period. Netlist was further awarded pre and post-judgment interest in addition to costs as the prevailing party in the action. This Final Judgment encompasses both the verdict in the jury trial, and the Court's ruling in the May 30, 2023 bench trial which is currently sealed due to the inclusion of confidential information. As noted in the Final Judgment, Samsung did not prevail on any of its equitable defenses in the bench trial. Netlist's second case against Samsung in the U.S. District Court for the Eastern District of Texas is scheduled to go to trial in April 2024 for infringement on a different set of patents.
|
WAMFF | Hot Stocks07:56 EDT Western Alaska Minerals extends Waterpump Creek mineralization - Western Alaska Minerals reports the first assay results from the initial step-out phase of its second-year drilling program at the 100% owned Waterpump Creek silver-rich Carbonate Replacement Deposit. Hole WPC23-0030 extends WPC to 495 meters in strike length. Highlights: Step-out drill hole WPC23-0030: Cumulative 71.6 meters of multiple high-grade zones; 22.0m of 146 gpt Ag, 3.3% Pb and 9.8% Zn; 40.2m of 262 gpt Ag, 10.9% Pb and 4.5% Zn, including; 5.3 meters of 729 gpt Ag, 24.1% Pb and 3.1 % Zn, and 8.6 meters of 493 gpt Ag, 22.9% Pb and 2.6% Zn; Extends the WPC system at least 45 meters down plunge to the south and demonstrates continuity of the system.; Extends WPC system to 495m in total length. Last Hurrah Drilling: The Company is excited to share visuals from the first drilling at Anaconda's "Last Hurrah" target, which appears to be an offset continuation of Waterpump Creek. Hole LH23-0005 cut 21.4m of strongly ultraviolet fluorescent "Barbecue Rock" in "Fugitive Calcite" veining, a proximal "exhaust" feature of CRD mineralization according to CRD expert, Dr. Peter Megaw, technical advisor to WAM. Similar Barbeque Rock surrounds mineralization at the Waterpump Creek deposit, where it occurs within 25m to 50m of high-grade CRD massive sulphide mineralization. "We welcome this proof that high-grade mineralization at Waterpump Creek remains open to the south and that the distinctive CRD alteration seen there is turning up in our drilling 700m farther south at Last Hurrah," said Kit Marrs, CEO of Western Alaska Minerals. "We look forward to continuing drilling at Last Hurrah to find the sulphides that the alteration is telling us should be nearby and trace it back towards WPC, which may just be the tip of the finger of a major CRD manto".
|
SCHW | Hot Stocks07:54 EDT Charles Schwab reports total client assets $8.24T as of month-end July - The Charles Schwab Corporation released its monthly activity report today. Company highlights for the month of July 2023 include: Core net new assets brought to the company by new and existing clients totaled $13.7B. Net new assets excluding mutual fund clearing totaled $11.9B. Total client assets were $8.24T as of month-end July, up 13% from July 2022 and up 3% compared to June 2023. Average margin balances were $63B in July, down 13% from July 2022 and up 2%compared to June 2023. Chief Financial Officer Peter Crawford commented, "As we continue to progress through the Ameritrade client conversion, we are observing initial evidence of the deal-related attrition we allowed for within the transaction math outlined at the announcement back in November 2019. These temporarily lower net flows reflect our organic asset gathering being offset by expected attrition within certain client cohorts, including recently converted Ameritrade retail clients as well as a modest number of Ameritrade advisor clients ahead of their planned transition to the Schwab platform in September. Additionally, we have elected to proactively resign from certain atypical custodial relationships previously served by Ameritrade's institutional business that are inconsistent with our approach to serving Registered Investment Advisors. We anticipate these temporary conversion-related dynamics will subside following the completion of the final transition group during the first half of 2024. Based on our experience with the first two conversion groups, as well as our latest projections, we believe that the ultimate attrition will be in-line with or slightly better than our initial estimates - approximately 4% of Ameritrade revenue prior to the deal or around 1% of combined total clientassets as of December 31, 2022. With all of this in mind, Schwab's competitive position remains strong as July new brokerage accounts increased 9% from the prior year to 303 thousand - marking the 9th consecutive month of new accounts exceeding 300 thousand. In addition to our overall July results demonstrating healthy client engagement and momentum, the average daily pace of client cash realignment outflows during the month remained generally consistent with prior periods, even as strong net equity purchasing persisted throughout the month. The continuation of this trend further underscores our confidence that we will see a resumption of deposit growth later this year."
|
ARAAF | Hot Stocks07:50 EDT Aclara Resources appoints Bonzi Yokomizo as GM, Brazil - Aclara Resources announce the appointment of Bonzi Yokomizo as General Manager of the wholly owned Brazilian subsidiary, effective Aug 10, 2023. Mr. Yokomizo joins Aclara with a long history leading large-scale mining projects across the globe, including the Americas. Africa, and the UK. His most recent role was Chief Projects Officer at Serra Verde, an ionic clays heavy rare earths mining project located in the State of Goias, Brazil, where he was instrumental in driving engineering for the project implementation, construction, and commissioning.
|
AOTVF | Hot Stocks07:48 EDT Ascot Resources provides 2023 outlook - With the financing package closed on January 19, 2023 and refinancing of the existing convertible debt on June 28, 2023, the Company is focusing on the completion of construction of the Project and achieving first gold production in early 2024. The key activities for remainder of 2023 include: Construction of the processing plant and associated surface infrastructure such that the plant is expected to be in pre-commissioning by the end of 2023; Completion of the tailings dam improvements and start up of the new water treatment plant by Q4 2023; Advancement of the Premier portal and underground development and additional underground development of the Big Missouri mine, as well as initial production stoping to provide mill feed for commissioning.; Maintaining a Health and Safety record of zero lost time incidents and achieving the 2023 goals outlined in the Company's 2022 Sustainability Report; Advancing the recruitment of site personnel in line with the site personnel plan by the end of 2023; Maintaining permitting and environmental compliance so that there are no delays in the project construction schedule; More exploration and infill drilling north and west of existing resources at the Premier Northern Light and Day zone resources areas
|
BRLXF | Hot Stocks07:46 EDT Boralex to continue to work on initiatives under 2025 Strategic Plan - The company said, "Boralex's 2025 Strategic Plan is built around the same four strategic directions as the plan launched in 2019 - growth, diversification, customers and optimization - and six corporate targets. The details of the plan, which also sets out Boralex's corporate social responsibility strategy, are found in the Corporation's annual report. Highlights of the main achievements for the quarter ended June 30, 2023, in relation to the 2025 Strategic Plan can be found in the 2023 Interim Report 2, available in the Investors section of the Boralex website. In the coming quarters, Boralex will continue to work on its various initiatives under the strategic plan, including project development, analysis of acquisition targets and optimization of power sales and operating costs. Finally, to pursue its organic growth, the Company has a pipeline of projects at various stages of development defined on the basis of clearly identified criteria, totalling 5,326 MW in wind, solar and energy storage projects, as well as a Growth Path of 971 MW of wind, solar and energy storage projects."
|
TMDI | Hot Stocks07:45 EDT Titan Medical appoints O'Brien to its board of directors - Titan Medical announced the appointment of Dr. Daniel O'Brien, MD, MBA, PhD to its Board of Directors. Dr. O'Brien will also serve on the Audit Committee of the Board.
|
FCN | Hot Stocks07:44 EDT FTI Consulting adds four Executive Vice Presidents - FTI Consulting announced the appointments of Lona Fowdur, Daniel Gaynor, Cagatay Koc and Loren Smith as Executive Vice Presidents within the firm's Compass Lexecon subsidiary in Washington, D.C. Previously, Dr. Fowdur was a Managing Director at Secretariat Economists. Dr. Gaynor joins from the Brattle Group, where he was a principal for 17 years. Dr. Koc joins from Secretariat Economists, where he was a Managing Director. Dr. Smith rejoins the firm from the Brattle Group, where he was the Practice Leader for Antitrust and Competition.
|
AMS | Hot Stocks07:43 EDT American Shared's GK Financing announces new agreement with Methodist Hospital - GK Financing, a subsidiary of American Shared Hospital Services, announced that it has extended its current agreement with Methodist Hospital, of San Antonio, Texas. The new agreement includes replacing its current Gamma Knife Perfexion system with Esprit, Elekta's newest Gamma Knife radiosurgery system. GKF expects to complete the installation by year end 2023 or early in 2024. Peter Gaccione, CEO of American Shared Hospital Services and President of GK Financing, commented, "Our longstanding partnership of 25 years with Methodist Hospital San Antonio will continue to grow with the replacement of their current Gamma Knife to the new Esprit system. Patients treated with Esprit can maintain their quality of life and go back to what they love doing after radiosurgery. We look forward to bringing this new technology to San Antonio that will benefit patients in their fight against cancer."
|
PTRUF | Hot Stocks07:42 EDT Petrus Resources revises 2023 capital budget - The company said, "Consistent with Petrus' commitment to maximize long term value for shareholders, the Company has pivoted its capital program for the remainder of 2023 to ensure spending remains within cash flow while also prioritizing its most strategic investments. This shift also positions Petrus to generate significant free cash flow allowing the Company to introduce a return of capital to shareholders through dividends and share buy-backs in the fourth quarter while continuing to reduce debt. Petrus is revising its 2023 capital budget guidance to $60 million to $75 million, $33.1 million of which has already been spent, largely on drilling. Remaining capital will be allocated as follows: 35% to adding infrastructure, including a pipeline to North Ferrier which will provide greater flexibility and lower operating costs in the development of our assets in this area; and 65% to new wells, including the completion of the four Ferrier wells drilled in Q1 2023, and new drilling in North Ferrier. The revised capital budget is expected to result in 2023 annual production of 10,000 to 10,500 boe/d and annual funds flow of $70 million to $80 million. Net debt at the end of the year is expected to be $40 million to $50 million, well below our target maximum net debt to annualized funds flow ratio of 1x. Free cash flow is expected to be in the range of $5 million to $15 million. In summary, the Board of Directors has approved a revised 2023 capital budget and guidance is as follows: Capital budget of $60 million to $75 million. Average annual production rate of 10,000 to 10,500 boe/d. Generate annual funds flow of $70 million to $80 million for 2023; Free cash flow of $5 million to $15 million, which will be used to introduce a return of capital to shareholders through dividends and share buy-backs in the fourth quarter and continue to reduce debt. The revised capital program is reflective of Petrus' flexible and disciplined investment strategy and strongly positions the Company for sustainable long term growth and value creation."
|
KURA FATE | Hot Stocks07:42 EDT Kura Oncology appoints Brian Powl as Chief Commercial Officer - Kura Oncology (KURA) announced the appointment of Brian Powl as Chief Commercial Officer. Powl has more than two decades of experience in the pharmaceutical and biotechnology industry, including extensive global experience in hematologic malignancies. Most recently, he served as Chief Commercial Officer for Fate Therapeutics (FATE).
|
MNTS | Hot Stocks07:40 EDT Momentus signs $746.07M contract with SDA - Momentus has signed a contract with the U.S. Defense Department's Space Development Agency, or SDA, for a Small Business Innovation Research Award, "Orbital Service Vehicle Enhancements to Meet Department of Defense (DoD) Mission Requirements." Under this award, Momentus will tailor the capabilities of its Vigoride Orbital Service Vehicle to support a full range of DoD payloads and mission requirements. The additional capabilities will be developed to a Critical Design Review maturity, setting the stage for a rapid transition to an in-space flight demonstration. The first contract action is valued at $746,073 with an option to add an additional $1,196,404 for further work.
|
NNDM | Hot Stocks07:39 EDT Nano Dimension acquires Additive Flow technology to drive software - Nano Dimension announced that it is acquiring the technology and intellectual property of the U.K.-based company Additive Flow, which supplies solutions for 3D design simulation and optimization. This acquisition signals a successful milestone in Nano Dimension's product development roadmap. Computer-aided engineering and design components are a core part of the Company's design-through-manufacturing product strategy. Alexander Pluke, Chief Executive Officer and Chief Technology Officer of Additive Flow commented: "The Additive Flow team is thrilled to join Nano Dimension. Our solution was born out of real engineering challenges we faced to harness the capability of advanced manufacturing. Our platform is built from the ground up to handle all the complex data and decisions of digital engineering, so teams can focus on their key goals. We are fortunate to have found a great partner in Nano Dimension where our innovation can be leveraged to its maximum potential. We look forward to building on our impressive track record and continuing to develop Additive Flow's software and enhance Nano Dimension's leading AM and AME product offerings."
|
ZYNE HRMY | Hot Stocks07:35 EDT Harmony Biosciences to acquire Zynerba - Harmony Biosciences (HRMY) announced a definitive agreement to acquire Zynerba Pharmaceuticals (ZYNE). Under the terms of the definitive agreement, Harmony will commence a tender offer to acquire all outstanding shares of Zynerba for a purchase price of $1.1059 per share in cash, or $60M in the aggregate, plus one non-tradeable contingent value right per share, representing the right to receive potential additional payments of up to $140M in the aggregate, subject to the achievement of certain clinical, regulatory and sales milestones. Zynerba's lead asset, Zygel, is the first and only pharmaceutically manufactured, synthetic cannabidiol, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. Zygel is currently being evaluated in a pivotal Phase 3 clinical trial for patients living with FXS. Cannabidiol, the active ingredient in Zygel, has been granted orphan drug designation by the FDA and the EMA for the treatment of FXS and for the treatment of 22q. There are currently no FDA-approved therapies to treat 22q. Harmony will fund the transaction from its existing cash on hand. As of June 30, 2023, Harmony had cash, cash equivalents and investment securities of $429.6M. Zynerba's existing cash and cash equivalent balance was approximately $36.0M as of June 30. The transaction is expected to close by Q4. Zynerba's board of directors unanimously recommends that Zynerba's stockholders tender their shares in the tender offer.
|
PNT | Hot Stocks07:33 EDT Point Biopharma expects cash to fund operations into 2026 - As of June 30, 2023, POINT had approximately $434.8 million in cash, cash equivalents, and investments, which is anticipated to fund operations into 2026.
|
RSGUF | Hot Stocks07:31 EDT Rogers Sugar sees 2023 capital project spending C$1M - The company said, "Following a solid performance in the third quarter of 2023, we expect to continue to deliver strong and stable financial results in 2023. Strong sugar demand and pricing is expected to continue and provide improved results, despite ongoing inflationary pressures. We expect our Maple segment will continue to face a challenging business environment for the remainder of 2023, as the unfavourable market and economic conditions encountered over the last year remain. We intend to mitigate these unfavourable market conditions with recently negotiated price increases, and newly implemented production automation initiatives. Sugar: We continue to expect the sugar segment to perform well in fiscal 2023. Underlying North American demand remains strong across all customer segments supported by favourable market dynamics. We expect that improvements in pricing implemented over the last year will continue to support our financial results positively, allowing us to mitigate the current impact of inflationary pressures on costs. In Taber, the harvest season delivered the expected volume of sugar beets, and the processing campaign was completed in early February. The current year crop yielded 104,000 metric tonnes, lower than the prior year production by 16,000 metric tonnes. The lower-than-expected production is attributable to unfavourable weather conditions encountered in the later stage of the current year growing period, which negatively impacted the sugar content of the sugar beets. We have increased the production plans of our Montreal and Vancouver cane sugar facilities and arranged for the temporary importation of refined white sugar from Central-America, to mitigate the production shortfall of our Taber facility and ensure we can support our commitments to our customers. In April 2023, we concluded a new two-year agreement with the Alberta Sugar Beet Growers for the supply of sugar beets to the Taber beet plant, for which the crop harvested in the fall of 2023 will be the first year of the agreed contract. We have slightly reduced our fiscal 2023 sales volume expectations to approximately 800,000 metric tonnes from 805,000 metric tonnes. The decrease of 5,000 metric tonnes reflects current market dynamics and timing differences in orders from large customers. While down slightly from previous expectations, our full-year 2023 volume outlook of 800,000 metric tonnes for the Sugar segment represents an increase of over 5,000 metric tonnes or 1% over 2022, which was our highest sales volume year on record. Overall, we expect the following year-over-year volume variances for our customer segments: Industrial, our largest segment, is expected to increase by 2%, as a result of the continuous strong demand supported by favourable market dynamics; Liquid volume is expected to grow by 1% driven by continued demand from existing customers; Consumer volume is expected to remain stable; and A planned 9% reduction in sales to the export markets for 2023, due to the growing demand and strong economics of the domestic market. Production costs and maintenance programs for our three production facilities are expected to be moderately impacted by the current inflationary pressures, and we continue to focus on cost control initiatives throughout our operations. We expect an increase in distribution costs in 2023, reflecting the incremental needs to move sugar between our facilities to support the demand of our customers and the recent related inflationary-based increases for logistics and supply chain costs. Administration and selling expenses are expected to be stable in 2023. We have been able to mitigate the impact of recent increases in interest rates and energy costs through our multi-year hedging strategy. We do not anticipate these increases to have a material impact on our operating results in the near future, as we expect our hedging strategy will continue to mitigate most of our exposure to such risks. However, we anticipate higher net finance costs, mainly from higher working capital requirements. Spending on regular business capital projects is also expected to remain stable for fiscal 2023. We anticipate spending approximately $25 million on various initiatives. This capital spending estimate excludes expenditures relating our recently announced production and logistic capacity expansion project in eastern Canada, which are currently estimated at $13 millions for fiscal 2023. Maple Products: For the remainder of 2023, we expect the global Maple industry to be negatively impacted by high inflation, resulting in lower global demand from retail customers. We anticipate the unfavourable impact related to the reduction in retail demand and the related increased competitiveness of the market will be mitigated by recently negotiated price increases with key customers, lower production costs driven by newly implemented automation projects and favourable recently negotiated supply agreements for packaging material. The expected spending for capital projects for 2023 is approximately $1.0 million, which is consistent with recent years. The main driver for the Maple segment projects is to improve productivity and profitability through automation."
|
LLY SGTX | Hot Stocks07:26 EDT Eli Lilly completes acquisition of Sigilon Therapeutics - Eli Lilly and Company (LLY) announced the successful completion of its acquisition of Sigilon Therapeutics (SGTX). The acquisition allows Lilly to continue researching and developing encapsulated cell therapies, including SIG-002, for the treatment of type 1 diabetes. Sigilon's common stock has been delisted from the NASDAQ Global Select Market and will be deregistered under the Securities Exchange Act of 1934, as amended.
|
TSHA | Hot Stocks07:26 EDT Taysha Gene Therapies expects cash to fund operations into 3Q25 - As of June 30, 2023, Taysha had $45.1 million in cash and cash equivalents. Taysha expects to receive gross proceeds of $150 million from the Private Placement, which is expected to close August 16, 2023, before deducting placement agent commissions and offering expenses. The net proceeds from the private placement, combined with the current cash and cash equivalents, are expected to fund its operational plans and capital requirements into the third quarter of 2025.
|
TSHA | Hot Stocks07:24 EDT Taysha Gene Therapies reports initial data from REVEAL Phase 1/2 trial - TSHA-102 in Rett syndrome: a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome, a rare genetic neurodevelopmental disorder caused by mutations in the X-linked MECP2 gene. TSHA-102 utilizes a novel miRARE platform designed to mediate levels of MECP2 in the CNS on a cell-by-cell basis without risk of overexpression. TSHA-102 has received Orphan Drug and Rare Pediatric Disease designations from the FDA and has been granted Orphan Drug designation from the European Commission. TSHA-102 is being evaluated in the REVEAL Phase 1/2 trial, a first-in-human, open-label, randomized, dose-escalation and dose-expansion study evaluating the safety and preliminary efficacy of TSHA-102 in adult females with Rett syndrome due to MECP2 loss-of-function mutation. Primary efficacy endpoints are patient assessments by clinicians using the Clinical Global Impressions Scale - Improvement, Rett Syndrome Hand Function Scale, and Revised Motor Behavior Assessment. Secondary endpoints include patient assessments by clinicians and caregivers using the Clinical Global Impressions Scale - Severity, the Rett Syndrome Behavior Questionnaire and other clinical assessment scales. Results from the first adult patient dosed in cohort one with TSHA-102 in the REVEAL Phase 1/2 trial: Well-tolerated safety profile with no treatment-emergent SAEs as of six-week assessment post-treatment. The following were demonstrated in key efficacy measures four weeks post-treatment: Clinical Global Impressions - Improvement scale adapted to Rett syndrome, a clinician-reported assessment of overall improvement using a seven-point scale, demonstrated a score of two indicating "much improved"; Clinical Global Impressions - Severity scale, a clinician-reported assessment of overall severity of a patient's illness using a seven-point scale, demonstrated a one-point improvement from the baseline score of six to a score of five; Rett Syndrome Behavior Questionnaire, a 45-item questionnaire to assess Rett syndrome characteristics, demonstrated a total score improvement of 23 points from the baseline score of 52 to a score of 29; Seizure diary demonstrated no quantifiable seizure events through week five post-treatment; No marked changes observed four weeks post-treatment in the Revised Motor Behavior Assessment, a 24-question clinician-reported scale measuring disease behaviors of Rett syndrome; Initial efficacy data and clinical observations supported by video evidence from PI six-weeks post-treatment indicate clinical improvements in multiple domains, including: Autonomic function with improvements in breathing patterns and sleep quality/duration, including the normalization of night-time behavior; Vocalization with increased social interest; Gross motor skills with the gained ability to sit unassisted for three minutes; Fine motor skills and hand function with the gained ability to hold an object, unclasp her hands and use her fingers to touch a screen; Further updates on available clinical data expected quarterly; Dosing of second patient cleared by the Independent Data Monitoring Committee and expected in Q3 2023, with continued dosing of adult patients in second half of 2023; U.S. FDA cleared the IND application for TSHA-102 in pediatric patients with Rett syndrome; CTA submitted to U.K. MHRA for TSHA-102 in pediatric patients with Rett syndrome
|
RCLF | Hot Stocks07:21 EDT Spectral receives ISO 13485 certification for AI-driven DeepView Wound Imaging - Spectral MD announces that it has received ISO 13485 certification for the manufacture and distribution of its AI-driven DeepView Wound Imaging System which is designed to provide immediate, accurate, and binary wound treatment assessments for Burn and Diabetic Foot Ulcer indications. Niko Pagoulatos, Chief Operating Officer of Spectral MD, said: "The receipt of ISO 13485 confirms Spectral MD's status as a global provider of medical devices that meet the highest standards of quality, reliability, and safety. We believe that this acknowledgement reflects Spectral MD's commitment to fostering a culture of continuous improvement, validates the robust sourcing and operational framework we have created, and provides an important competitive advantage as we continue our regulatory submission initiatives and advance towards product commercialization." As announced on April 11, 2023, Spectral MD Holdings has entered into a business combination agreement to combine with Rosecliff Acquisition Corp I, a special purpose acquisition company listed on Nasdaq.
|
VIRI | Hot Stocks07:20 EDT Virios Therapeutics announces halt to at-the-market offering sales - Virios Therapeutics has advised its sales agent, JonesTrading Institutional Services to cease sales under the Capital on Demand Sales Agreement entered into between the Company and JonesTrading on July 14, 2023. "Based on current market conditions and investor sentiment, we believe it is in the best interest of the Company and its stockholders to halt such sales," noted Greg Duncan, Chairman and Chief Executive Officer of the Company. The Company's management team is focusing its attention on short-to-medium term operational priorities that are within the current operating budget, including: Preparing transition of IMC-1 Phase 3 development program as a treatment for fibromyalgia. Executing our IMC-2 confirmatory Long-COVID study with the Bateman Horne Center, while exploring non-dilutive funding options to support advanced IMC-2 development. Preparing for a Pre-Investigational New Drug meeting with the Food & Drug Administration. Exploration of Potential Partnerships for both the FM and LC Programs.
|
ADBRF | Hot Stocks07:20 EDT Aldebaran Resources announces it has earned a 60% interest in Altar Project - Aldebaran Resources announces it has completed the $30M in expenditures required to earn a 60% interest in the Altar copper-gold project pursuant to its joint venture agreement with Sibanye-Stillwater. Additionally, the Company has notified Sibanye-Stillwater that it intends to proceed with the second option to spend US$25 million over a three-year period to acquire an additional 20% interest in the Altar project. Upon completion of the second option, Aldebaran will own an 80% interest in the Altar project while Sibanye-Stillwater will own a 20% interest. As of June 30, 2023, the Company has spent approximately US$38 million on the project. John Black, Chief Executive Officer of Aldebaran, commented as follows: "We're happy to report that we've officially earned a 60% interest in the Altar project and are on our way to earning an eventual 80% interest. When we picked up this project in 2018, we understood that it had immense potential; however, it has exceeded our expectations on several fronts. Altar represents one of the largest undeveloped copper projects in the world, and we are excited to continue to unlock its potential to help supply necessary copper resources to fuel the worldwide green energy revolution."
|
ATMV | Hot Stocks07:18 EDT AlphaVest Acquisition enters merger agreement with Wanshun Technology - AlphaVest Acquisition Corp announced the execution of a Business Combination Agreement with Wanshun Technology Industrial Group Limited, primarily a peer-to-peer marketplace for on-demand rides hailing services in China. The transaction will be structured as a business combination with ATMV's wholly owned subsidiary, AV Merger Sub, and is anticipated to result in ATMV shareholders receiving shares of Wanshun capital stock valued at approximately $300 million. The transaction has been approved by the boards of directors of both ATMV and Wanshun and is expected to be consummated in the fourth quarter of 2023 or early 2024, subject to regulatory approval and respective stockholder approval by the stockholders of ATMV and the stockholders of Wanshun and the satisfaction of certain other customary closing conditions. Wanshun, based in Shenzhen, China, and established in 2016, operates an app-based ride-hailing service. Building on its established ride-hailing business, Wanshun is creating an online and offline ecosystem by integrating complimentary verticals including physical stores/showrooms for existing and new drivers, customized white-label electric vehicle and smart life service. Upon the closing of the Business Combination, the combined company is expected to operate under the name Wanshun Technology Industrial Group Limited and remain a NASDAQ-listed public company trading under a new ticker symbol. Wanshun's executive management team will continue to lead the combined company. There can be no assurance that the combined company will remain listed on NASDAQ.
|
MDNA | Hot Stocks07:16 EDT Medicenna Therapeutics appoints Meadows as CBO - Medicenna Therapeutics announced the appointment of Brent Meadows, MBA, as its Chief Business Officer, CBO, as part of the Company's plans to establish a world-class C-suite in Boston, the industry's largest biotech hub. Prior to joining Medicenna, Meadows served as CBO at OncoOne.
|
TSHA | Hot Stocks07:15 EDT Taysha Gene Therapies announces $150M private placement financing - Taysha Gene Therapies has entered into a securities purchase agreement for a private placement financing that is expected to result in gross proceeds of approximately $150 million, before deducting placement agent commissions and offering expenses. The PIPE was led by new investor, RA Capital Management, with participation from a large institutional investor, PBM Capital, RTW Investments, LP, Venrock Healthcare Capital Partners, TCGX, Acuta Capital Partners, Kynam Capital Management, LP, Octagon Capital, Invus, GordonMD Global Investments LP, and B Group Capital. In the PIPE, Taysha is selling an aggregate of 122,412,376 shares of its common stock at a price of $0.90 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 44,250,978 shares of common stock at a purchase price of $0.899 per pre-funded warrant. Each pre-funded warrant has an exercise price of $0.001 per share of common stock and is immediately exercisable and remains exercisable until exercised in full. The PIPE is being conducted in accordance with applicable Nasdaq rules and was priced to satisfy the "Minimum Price" requirement. The PIPE is expected to close by August 16, 2023, subject to customary closing conditions. The pre-funded warrants will only be exercisable upon receipt of stockholder approval of an increase in the authorized shares of Taysha's common stock, which Taysha will first seek to obtain at an annual meeting of stockholders to be held by December 31, 2023. Jefferies is acting as exclusive placement agent in the private placement.
|
MESA | Hot Stocks07:15 EDT Mesa Airlines launches $20,000 direct-entry captain referral incentive - Mesa Airlines is launching a one of a kind Direct-Entry Captain Referral Program, offering a $20,000 incentive to anyone who successfully refers a qualified pilot for employment with the company as a Captain. "We are thrilled to launch this program as a way to reward anyone willing to help us grow and attract new talent to our company," said Jonathan Ornstein, Chairman and CEO of Mesa Airlines. "We are looking for motivated and qualified pilots who want to join our family and grow with us as we expand our operations. This is a wonderful opportunity to advance your career, have a direct flow to United through their Aviate program, and earn a generous bonus at the same time."
|
PDSB MRK | Hot Stocks07:13 EDT PDS announces submission of Phase 3 protocol to FDA to initiate VERSATILE-003 - PDS Biotechnology (PDSB) announced the submission to the U.S. Food and Drug Administration, FDA, of an updated Chemistry, Manufacturing and Controls, CMC, package and a Phase 3 multicenter registrational protocol to the company's Investigational New Drug, IND, submission to evaluate the combination of PDS0101 and KEYTRUDA, Merck's (MRK) anti-PD-1 therapy, for the treatment of recurrent or metastatic human papillomavirus 16-positive head and neck squamous cell carcinoma, HNSCC. The protocol was developed in accordance with guidance from the FDA on key elements of the Phase 3 program to support the eventual submission of a Biologics License Application. The Phase 3 trial, named VERSATILE-003, is a randomized, active comparator-controlled study designed to investigate the safety and efficacy of PDS0101 combined with KEYTRUDA compared to KEYTRUDA monotherapy in immune checkpoint inhibitor-naive patients with recurrent or metastatic HPV16-positive HNSCC. The primary efficacy endpoint for VERSATILE-003, per the protocol, is overall survival. PDS Biotech anticipates initiating the VERSATILE-003 Phase 3 trial in the fourth quarter of 2023.
|
BTAI | Hot Stocks07:11 EDT BioXcel Therapeutics expects cash to last through mid-2024 - Cash and cash equivalents totaled $127.5 million as of June 30, 2023. The Company is undertaking a strategic reprioritization, which includes a reduction in force of more than 50%, that is expected to reduce expenses significantly. In the absence of additional capital becoming available to the Company under the strategic financing agreements or otherwise, the Company estimates that its current cash and cash equivalents will last through mid-2024. The Company's previously disclosed cash runway projection assumed the full utilization of its strategic financing agreements with Oaktree Fund Administration LLC and Qatar Investment Authority. Based on recent events, the Company is not likely to be in a position to meet the milestones required to access additional capital under the financing agreements. The Company has initiated discussions with its strategic financing partners to amend the agreements. Successful modification of these agreements could further extend the Company's cash runway.
|
BTAI | Hot Stocks07:10 EDT BioXcel Therapeutics to reduce workforce from 190 to 80 employees - Following a comprehensive review of the business, the Company has determined to focus on high-potential agitation-market opportunities using its innovative, AI-based clinical drug development platforms. The Company intends to reduce more than 50% of its cash burn to approximately $80 million on a go-forward annualized basis. The Company will also be reducing its workforce from approximately 190 to 80 employees. These actions include a shift in commercial strategy for IGALMI in the institutional setting, a reduction of in-hospital commercialization expenses, a suspension of programs no longer deemed core to the Company's business, and a shift in focus to develop BXCL501 for use in the at-home setting in the treatment of agitation in schizophrenia, bipolar disorders, and in patients with mild to moderate dementia due to probable Alzheimer's disease.
|
GMDA | Hot Stocks07:08 EDT Gamida Cell continues to explore alternatives for a 'resourced launch' - The company continues to work with Moelis & Company LLC to engage and advance discussions with multiple parties as part of its efforts to explore alternatives to support a fully resourced launch.
|
TECH | Hot Stocks07:05 EDT Bio-Techne ends collaboration with Akoya Biosciences - Bio-Techne announced that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use with the PhenoCycler-Fusion System. The decision was made following best efforts to achieve the intended program goals. "Bio-Techne remains focused on providing the greatest value to the spatial biology community," said Kim Kelderman, President of Bio-Techne's Diagnostics and Genomics Segment. "We are actively expanding the capabilities of our gold-standard RNAscope technology to enable greater utility in multiomic spatial applications and plan to accelerate the development and commercialization of the first fully automated and scalable spatial multiomics workflow on the Lunaphore COMET system." Bio-Techne will continue to support its customers utilizing RNAscope assays in conjunction with Opal reagents and PhenoImager HT systems purchased from Akoya.
|
USEG | Hot Stocks07:04 EDT U.S. Energy suspends dividend payment policy - Additionally, the Company's board of directors paid a $0.0225 per share dividend to shareholders of record on May 19, 2023. Subsequently, the Board of Directors has suspended the Company's dividend payment policy, with the associated capital planned to go towards accelerating the Company's share repurchase program.
|
USEG | Hot Stocks07:03 EDT U.S. Energy board authorizes $5M share repurchase program - Consistent with the Company's shareholder returns strategy, during the second quarter of 2023, the Company announced that its board of directors authorized a share repurchase program under which the Company may purchase up to $5.0 million of its outstanding shares of common stock in the open market, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934.
|
MSCI | Hot Stocks06:48 EDT MSCI acquires Burgiss - MSCI has entered into a definitive agreement to acquire the remaining 66% of The Burgiss Group for $697M in cash. Burgiss is a Hoboken, New Jersey-based market-leading provider of data, analytics, and technology solutions for investors in private assets. Since its initial investment in January 2020, MSCI will have invested an aggregate of $913M to acquire all of Burgiss. With over 35 years of expertise in alternative investments, Burgiss offers private asset data, analytics, and software applications, including performance data that dates back to 1978. The Burgiss dataset covers over 13,000 private asset funds around the world, representing $15T in cumulative investments across private equity, private real estate, private debt, infrastructure, and natural resources in 195 countries. Burgiss serves approximately 1,000 clients in 40 countries with 650+ employees across the U.S., Europe, Asia Pacific, and South Africa. This acquisition will also expand MSCI's suite of multi-asset class technology solutions with the Burgiss Caissa Platform. MSCI anticipates funding the purchase consideration from existing liquidity sources. Burgiss is expected to generate over $90M of revenue in 2023 with an EBITDA margin and operating income margin in the mid-teens. The transaction is expected to close in Q4.
|
BNTX | Hot Stocks06:46 EDT BioNTech names James Ryan as Chief Legal Officer - BioNTech announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal Officer, effective September 1. As part of the Management Board, James Ryan will continue to lead the company's corporate legal strategy and global legal operations including transactions, corporate governance, securities, intellectual property, insurance, data privacy, among others. Prior to his appointment to the Management Board, James Ryan served as the company's General Counsel and Senior Vice President Legal & IP.
|
NFGC MRTMF | Hot Stocks06:39 EDT New Found Gold signs MOU with Maritime Resources for use of Pine Cove Mill - New Found Gold (NFGC) has entered into a non-binding memorandum of understanding with Maritime Resources (MRTMF) pursuant to which the company has been granted the right to conduct due diligence and exclusivity to negotiate with Maritime regarding a toll milling agreement at the existing Pine Cove Mill located at the Point Rousse project near Baie Verte, Newfoundland and Labrador. The project's attributes include: high-grade gold mineralization at many of the Queensway project's zones starts in the bedrock just 3-6m below surface including at Keats, Iceberg and Keats West; mineralization at Keats, Iceberg and Keats West is easily accessible and located less than one kilometre from the Trans-Canada Highway: renewable hydroelectric sourced high-tension powerlines run directly across the project adjacent to the Keats, Iceberg and Keats West zones. The Pine Cove Mill is a fully permitted gold processing facility that was operating as recently as Q1 of this year and is rated at 1,400 tons per day located on the Baie Verte peninsula, approximately 270km from the Queensway project by paved highway.
|
WLK | Hot Stocks06:32 EDT Westlake increases quarterly dividend 40% to 50c per share - Westlake declared a regular dividend distribution of 50c per share for Q2, an increase of approximately 40% from the 35.70 cents per share of Q1. This dividend will be payable on September 12 to stockholders of record on August 25.
|
CHK SBOW | Hot Stocks06:26 EDT Chesapeake announces sale of final Eagle Ford package for $700M - Chesapeake (CHK) announced that it has executed an agreement to sell its remaining Eagle Ford assets to SilverBow Resources (SBOW) for $700M, bringing the total proceeds from its Eagle Ford exit to more than $3.5B. Chesapeake has agreed to sell approximately 42,000 net acres and approximately 540 wells in the condensate rich portion of its Eagle Ford asset located in Dimmit and Webb counties, along with related property, plant and equipment. During the second quarter of 2023, average net daily production from these properties was approximately 29,000 barrels of oil equivalent, or boe, which generated approximately $50M of EBITDAX. As of December 31, 2022, net proved reserves associated with these properties were approximately 124M barrels of oil equivalent, or mmboe. Chesapeake expects the transaction will close, subject to certain regulatory approvals and consents, in 2023, with an effective transaction date of February 1. The company will receive $650M upon closing, subject to customary adjustments, with the final $50M installment paid one year from the closing date. SilverBow has also agreed to pay Chesapeake an additional contingent payment of $25M should oil prices average between $75 and $80 per barrel WTI NYMEX or $50M should WTI NYMEX prices average above $80 during the year following the close of the transaction, which could increase total proceeds of the deal to $750M. Chesapeake anticipates the proceeds will be available to further strengthen its balance sheet and for its share repurchase program.
|
SBOW | Hot Stocks06:22 EDT SilverBow Resources acquires Chesapeake Energy's South Texas Position - SilverBow Resources has entered into an agreement to acquire Chesapeake Energy's oil and gas assets in South Texas for a purchase price of $700M, comprised of a $650M upfront cash payment due at closing and an additional $50M deferred cash payment due 12 months post close, subject to customary adjustments. Chesapeake may also receive up to $50M in additional contingent cash consideration based on future commodity prices. The Transaction is expected to close by year-end 2023. The transaction is expected to be funded with cash on hand, borrowings under the company's First Amended and Restated Senior Secured Revolving Credit Agreement, and the company's amended second lien notes led by EIG. In conjunction with the Chesapeake Transaction, the company has secured $425M of incremental commitments which will increase lender commitments under the Credit Facility to $1.2B, and the Second Lien Notes will be upsized by $350 M, which will increase lender commitments under the Second Lien Notes to $500M and extend the maturity date for the Second Lien Notes to December 15, 2028. The estimated impact to SilverBow from the Chesapeake Transaction increases expected 4Q23 net production to 87,000-99,000 Boe/d, ~50% oil/NGLs, adds critical scale with ~$825M-$925M of pro forma next 12 months EBITDA, free cash flow in 2024 expected to increase by more than 80%. Chesapeake expected production is ~31,000-33,000 Boe/d ~60% oil/NGLs for 4Q23. To protect the financial benefits of the Chesapeake Transaction, SilverBow plans to hedge a significant portion of the company's expected volume for the next three years.
|
HUT | Hot Stocks06:08 EDT Hut 8 Mining provides update on business combination with U.S. Data Mining Group - Hut 8 Mining announced that, in connection with its previously announced business combination with U.S. Data Mining Group, Inc. dba US Bitcoin Corp to be effected by way of a court-approved plan of arrangement under the Business Corporations Act, the company has obtained an interim order from the Supreme Court of British Columbia. The Interim Order provides for, among other things, the holding of a special meeting of the holders of common shares of the company to approve the arrangement. The special meeting is scheduled to be held on September 12.
|
KBR LUNR | Hot Stocks06:05 EDT KBR joint venture with Intuitive Machines awarded $719M NASA contract - KBR (KBR) announced NASA's award to the Space & Technology Solutions team, a KBR joint venture with Intuitive Machines (LUNR), to provide multidisciplinary engineering for some of NASA's most critical space orbital systems in its Applied Engineering and Technology Directorate at Goddard Space Flight Center, or GSFC, in Maryland. The Government Accountability Office, or GAO, has denied all protests of this award. The Omnibus Multidiscipline Engineering Services, or OMES, III contract has a five-year period of performance with a total value of $719M. The cost-plus-fixed-fee indefinite-delivery, indefinite-quantity contract directly aids the primary support vehicle for the Joint Polar Satellite System program, the backbone of both short- and long-term weather forecasts, as well as NASA's Exploration and In-space Services projects division, which develops groundbreaking, more sustainable technologies to service spacecraft and pioneer in-space assembly and manufacturing. As a part of OMES III, KBR will provide electrical engineering, instrument systems and technology services, exploration and mission support services, as well as mission engineering and systems analysis for the study, design, development, fabrication, integration, testing, verification and operations of spaceflight, airborne, and ground system hardware and software.
|
COIN | Hot Stocks06:02 EDT Coinbase announces expansion in Canada - Coinbase announced its Canadian expansion with a series of new offerings that demonstrate its commitment to Canada as a priority Go Deep market. Through its partnership with Peoples Trust Company, part of Peoples Group, Coinbase is now providing access to Interac e-Transfers to 100% of Canadian Coinbase users, making it secure and simpler than ever to move money in and out of your account. This will make cryptocurrencies more accessible to millions of Canadians. Interac availability was the most requested feature by Canadian users, and today's news demonstrates Coinbase's plan to build a platform that is for Canadians, by Canadians. Depositing funds to Coinbase using Interac is free and almost instant. In the last month, over 50% of deposits have been made through Interac e-transfer. Starting today, Canadian Coinbase users can also maximize the full potential of crypto with the best of Coinbase through membership with Coinbase One. Free for all users for 30 days, Canadians now have access to zero trading fees, boosted staking rewards, priority 24/7 support, and more.
|
PHG | Hot Stocks05:13 EDT Exor purchases 15% interest in Philips - Philips and Exor, the Netherlands-based diversified holding company, announce they have entered into a relationship agreement as a result of which Exor has bought a 15% shareholding in Philips. This investment by Exor is supportive of Philips' leadership, strategy and value creation potential and provides for Exor to nominate one member to the supervisory board of Philips. The discussions between Exor and Philips were initiated in the context of Exor's stated interest in increasing its presence in the healthcare and technology sectors. Exor's investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases and an agreement with a major financial institution. The relationship agreement includes Exor's commitment to be a long-term minority investor and the right to propose one member to the Supervisory Board, as well as several customary conditions. While Exor does not plan to buy further Philips shares in the short term, over time the relationship agreement provides for Exor, at its discretion, to increase its participation to a maximum limit of 20% of Philips' outstanding ordinary share capital.
|